Golden Gate University School of Law

GGU Law Digital Commons
California Senate

California Documents

11-21-1989

Public Hearing on Evaluation of Needle Exchange
Programs as a Way to Combat AIDS
Senate Committee on Health and Human Services

Follow this and additional works at: http://digitalcommons.law.ggu.edu/caldocs_senate
Part of the Health Law and Policy Commons, and the Legislation Commons
Recommended Citation
Senate Committee on Health and Human Services, "Public Hearing on Evaluation of Needle Exchange Programs as a Way to Combat
AIDS" (1989). California Senate. Paper 91.
http://digitalcommons.law.ggu.edu/caldocs_senate/91

This Hearing is brought to you for free and open access by the California Documents at GGU Law Digital Commons. It has been accepted for inclusion
in California Senate by an authorized administrator of GGU Law Digital Commons. For more information, please contact jfischer@ggu.edu.

CALIFORNIA LEGISLATURE

SENATE COMMITTEE ON HEALTH
AND HUMAN SERVICES
SENATOR DIANE WATSON

Public Hearing On

EVALUATION OF NEEDLE
EXCHANGE PROGRAMS AS
A WAY TO COMBAT AIDS

Museum of Science and Industry
Kinsey Auditorium
700 State Drive
Los Angeles, California

504-S

PUBLIC HEARING

1

STATE OF

2
3

SE~ATE

CALIFOR~IA

COMMITTEE ON HEALTH AND HUMAN SERVICES

4
5

In the

6

Evaluation of Needle
Exchange Programs as
a Way to Combat AIDS

7

~latter

of:

)
)
)
)
)

OR !r:; hiAL
(\,._

l\, \ -

______________________ )

8
9

Museum of Science and Industry
Kinse~ Auditorium
70() State Drive
Los An~eles, California

10
11
12

Tuesday,
November 21, 1989

13
14
15

Informational

hearin~

regarding the above-

16

entitled matter was conducted in a public hearing

17

at 1:35 p.m.

18
19

20
21

APPEARA:;CES :
Senate Health and Human Services Committee
Senator Diane Watson - Chairperson

22

23
24

25

PETERS SHORTHAND REPORTING CORPORATION
3336 BRAOSHAI'. ROAD. SUITE 2<i0
SIICRAMENTO CALIFORNIA

~27

ii

I ND E X

1

2
Speaker

3

3

George Clark
4
Michael Smith, M.D.

27

h!ark Hadsen

30

David Werdegar, U.D.

39

Patricia Evans

47

Neil Flynn, M.D.

54

Jay Cavanaugh

60

Gil Gerald

70

Sherry Conroy

78

Thomas Horowitz, H.D.

82

5
6
7
8
9
10
11
12
13

Captain Bruce

~itchell

86

14

Commander Larry L. Anderson
15

104

John Brown
16
17
18

19
20
21
22

23
24

25

PETERS SHORTHAND RE"PORTING CORPORATION
3336 B"<'-OSHA:. "0AO. SUITE 240
SACRAMENTO (L"IFORNlA 95827
TELEPHONE :·•6) 362·2345

1

AFTERNOON SESSION
(1:35 p.m.)

2

SENATOR WATSON:

3

Good afternoon and I'd like

4

to welcome all of you to this special hearing of the

5

senate Health and Human Service Committee.

6

convened this afternoon to explore one question, "Are

7

needle exchange programs effective in combating AIDS?".

8
9

We have

Needle exchange programs on a one to one basis,
needles on the street for uninfected needles, is something

10

that we want to hear more about.

In other words, dirty

11

needles are exchanged for clean ones without adding to the

12

total number of needles on the streets.
These programs have become a subject of intense

13
14

debate in the field of AIDS prevention and substance abuse

15

treatment.

16

decrease the spread of HIV infection among HIV users.

17

Opponents argue that such programs condone and promote

18

illegal drug use.

19

this controversy over the next few hours as we hear from

20

expert witnesses on the beneficial and harmful effects of

21

needle exchange programs in efforts to curb HIV or IV drug

22

use and the spread of AIDS.

23

Proponents claim needle exchange programs may

We will have the opportunity to explore

Early in July of this year, the California AIDS

24

Leadership Committee issued its strategic plan for the

25

California continuing response to HIV disease.

The

committee identified the problem of the rise in HIV
infection among IV drug users due to the sharing of drug
3

i

ection paraphernalia among users.

The committee

4

recommends to this problem, -- The committee

5

recommendation to this problem is the enactment of

6

legislation to establish and fund pilot paraphernalia

7

exchange projects in California.

8

does caution and emphasize that such programs are not an

9

end in themselves.

The committee, however,

The report states that paraphernalia

10

exchange programs should be viewed as merely one component

11

of a comprehensive program designed to discourage drug

12

abuse as well as prevent further spread of HIV infection

13

among IV drug users, their sexual partners, and their

14

offspring.

1

of HIV Infection among IV drug users.

16

sighted for the legislature to set the policy direction

17

r health officials in this state on needle exchange

There is no easy solution to address the rise
It would be short-

18

pr

19

understanding the controversy surrounding these programs.

20

rams without public input and exploring and

So, I want to thank all of you for coming and
I'd like now to begin the dialogue between the proponents
and the opponents of the needle exchange program.
I'd like to introduce now our first speaker,
George Clark.

Mr. Clark is the Coordinator of Prevention

POint, a needle exchange program currently operating on an

3
1

ad hoc basis in the city of San Francisco.

2

Clark, that you have some slides that you want to show?

3

MR. CLARK:

4

SENATOR WATSON:

5

our heads or should we -MR. CLARK:

6

I believe, Mr.

Yes.
Okay, that may be seen over

I think you can see them.

You'll

7

turn around when the slides come on. They'll dim the

8

lights when it happens,or they'll dim them now,and they'll

9

be ready.
SENATOR WATS0N:

10

11

Okay.

STATEMENT BY GEORGE CLARK

12

MR. CLARK:

Hi, I'm George Clark.

I'm one of

13

the people who work with Prevention Point, a street-based

14

needle exchange in San Francisco, California.

15

here today to present information on the issue of needle

16

exchange as an HIV intervention and, in particular, about

17

Prevention Point, San Francisco's street based needle

18

exchange.

19

two requests of you.

I've come

However, before I do that I would like to make

The price of needle exchange as an HIV

20

21

prevention/intervention is a complex issue.

22

your full attention to weigh and analyze the pros and

23

cons.

24

lose sight that it is a completely human problem.

25

decisions that you make about this issue will affect the

However,

It demands

I believe it is important that we don't
The

4
1

2

lives of hundreds of individuals.

It's important that we

esent these individuals into the process.

This can only

3

remain an academic, moralistic and intellectual debate in

4

the absence of the injection drug users.

5

our needle exchange can be heard in the words of Nancy, a

6

32-year-old heroin user who has been using for 10 years.

7

She said this in a recent interview: "You know, a lot of

8

people here are using clean needles now, whereas before

9

they weren't.

10

know,

The effects of

Everybody was sharing needles before.

I've got to have my own because I'm positive,and

know, if I didn't have them here they'd use mine:

11

You

I

so, i f you

12

know i t .

13

listen to the information you get today from the different

But now it's not like that anymore.

"

presenters, present Nancy in your mind and the effect of
having access to sterile injection equipment does to
her.
I also want to request you to be prepared to do
some difficult evaluation.

Some of the findings in needle

xchange research are counter-intuitive; they only make
after deeper analysis.
decisions.

So don't be prone to jump to

People are quick to conclude that needle

hange promotes drug use.

However, in the Netherlands

re needle exchange has been implemented since 1980 for
ontinues as an intervention during the Hepatitis B
ic, and now for HIV, there have been exchanges of

5

hundreds of thousands of syringes, and there is no evidence
2

that it promotes drug use.

The number of drug users in

3

Amsterdam remains stable from the period of 1983 through

4

1988.

5

from 26.8 in 1983 to 30.8 in 1988.

6

the percentage of young drug users, those are drug users

7

under the age of 25, diminished from 14.4 percent of the

8

injection drug-using community to 3.4 percent in '88.

9

This contradicts the argument that access to sterile

The average age of an injection drug user has risen
That happened while

10

injection equipment will promote needle use among users.

11

The fact is that 38 percent of the people who participated

12

in Amsterdam's needle exchange have reduced their drug

13

use.

14

During the period of 1983 to 1987, the number of

15

drug users seeking drug-free treatment doubled.

16

indicates that it may even be that needle exchange is

17

assisting people to choose out of the drug life.

18

This

What is true wherever needle exchange has been

19

implemented as an HIV intervention is that participants

20

have reported safer needle use.

21

Waters of the Urban Health Study in early 1989, only 18

22

weeks after the beginning of our intervention, indicated

23

that the more often the injection drug user used our

24

program, the more likely they were not to share.

25

Data gathered by John

Prevention Point is a coalition of community-

6

based AIDS prevention organizations and people which
ncludes the Third world Advisory Task Force and the
Latino Coalition on AIDS.
4

Its members include health care

workers, people in recovery, social scientists, HIVinfected people, teachers, lawyers, painters and community

6

organizers.

7

private donations.

8

spread of HIV among high risk communities that are at risk

9

through contaminated needles.

10

Prevention Point is supported entirely by
Our objective is to intervene in the

Used needles are accepted

into a bio-hazardous waste container, and new sterile
ins lin syringes are dispensed on a one-for-one exchange
bas s.
The syringes in the past were marked and

13

14

15

6

monitored to establish return rates, and several
ndependent experienced AIDS research organizations are
c nducting evaluations and studying Prevention Point.
Prevention Point sees needle exchange as but one
part o

a com

ehensive HIV prevention program.

Bleach,

oms, cultural and linguistic-appropriate education,
t

21

r

dr

ach, risk reduction counseling, greater access to
mary health care, perinatal care and a wide range of
treatment are all necessary.

we began because we

knew that there was shortages of injection equipment that
were promoting sharing.

In the research and the

ter a ture, the major reason for sharing syringes given by

7

injection drug users are shortages of equipment and having
2

laws against possession of sterile injection equipment.
A number of us who are working on a research

3
4

project and as part of an interview that we administered

5

to injection drug users, asked for their ideas about how

6

to stop the spread of AIDS in their communities.

7

and again people spoke of being forced to share by

8

shortages of syringes and suggested that we make sterile

9

injection equipment more available.

10

Let's see, does this work?

11

SENATOR WATSON:

Again

While you are trying to get

12

that to work, what do you do with the needles that you

13

collect?

14

MR. CLARK:

we currently take them to the

15

Department of Public Health who disposes them as bio-

16

hazardous waste.

17

SENATOR WATSON:

18

MR. CLARK:

19

SENATOR WATSON:

20

21

Are they taking them?

Yes.
Could they incinerate them

or melt down the metal that's in the needle?
MR. CLARK:

I don't know exactly

--

--

Doctor

I don't know exactly how

22

Werdegar will present later

23

that kind of bio-hazardous waste gets dealt with.

24
25

SENATOR UATSON:

Because they are ending up

on beaches and in other places and I'm wondering why they

8

don't try to melt the metal.
MR. CLARK:

2

I think when they end up on beaches

3

they're being disposed of illegally and not properly as

4

bio-hazardous waste.

5

coast, that was the case of people that were just taking

6

them and putting them into garbage when it should have

7

been bio-hazardous waste.

8

SENATOR WATSON:

9

MR. CLARK:

So I think, especially on the East

Right, okay.

On November 2nd we began our

10

intervention.

11

November 16th, 1989, so that's a year later, in a single

2

On that day we exchanged 13 needles.

On

two hour period, we exchanged over 2100 syringes with more
than 360 individuals.

That is in three locations in the

14

streets of San Francisco.

15

1 88, we have exchanged 31,448 syringes and have made
7,352 client contacts.

In total, since we started in

These total client contacts, some

em are duplicated, we can't tell how many are-Initially, we began with two teams.
f

the syringes we first got.

Here are

This, in fact is what

all -- sort of, you know how people always hang up the
t dollar

hey got?

That was one of the syringes we

got, so you can see the condition of the syringe.
t

se are initially the syringes we got the first time.

SENATOR WATSON:
are contaminated?

Do you know if those need1es

So

9
MR. CLARK:

We don't, but in cooperation with

2

the University of California, we're attempting to better

3

understand the technology.

4

is possible to do PCR's on syringes, to test for HIV

5

prevalence.

6

verification of self-report measures, since most of the

7

evidence is self-report.

8
g

We're also interested to do it as a

This is the take from that night where we did
2100 syringes so you can see.
SENATOR WATSON:

10
11

My goodness.

You did this

in one night in an exchange program?
MR. CLARK:

12

2100 in one night in two hours at

13

three different locations.

14

night were 360 individuals.

15

until ten.

16

The people in Australia -- it

The total client contacts that
We'll exchange one-to-one up

Go to the next slide.

This is our Prevention

17

Point needle exchange program work by month so you can see

18

how quickly --well, it looks like a normal curve.

19

ends the month of October, the data was only in up until

20

October 18th; in fact, in October we exchanged slightly

21

over 6,400 syringes, so it looks like the beginning of a

22

normal curve that keeps going on.

23

The next slide please.

24

SENATOR WATSON:

25

they can get clean needles?

It

Are they using more because

10

MR. CLARK:

I think they use a needle less times

2

so in a way they're using more needles physically.

3

There's no evidence in the literature that people shoot up

4

more.

5

staff and the Urban Health Study has a grant through AMFOR,

6

and it will in the beginning of December gather more data

7

about, self-report data --

We only have preliminary data.

SENATOR WATSON:

8

9

MR. CLARK:

Our location in-- it's interesting.

The two different types of

one team is a roving team

hat goes place to place.

In fact, if you go to the next

12

slide we'll look at the street scene.
li

15

Now is this mostly heroin

used or is this a mixture?

10

13

John Waters of USC

ne

, this is more needles.

We have lots of pictures of

les.
Here's the street location.

16

erloin on Taylor and Ellis.

17

Again, another

two ways.

That's in the

Initially, we did this

We did a stationary team that stays in one

lace and people come to, and a roving team that moves
t

r ugh civic center, down UN plaza and then down to 6th
et.

That was done because we wanted to see how it

uld work.
SENATOR WATSON:

Do you get hassled?

Are you

ssled by law enforcement?
MR. CLARK:

We have been hassled on two

11

occasions.
2

one was when we were having what we called the

"media circus" which was when the media wanted to come on
we said all right, we'll do it one night, because

3

site.

4

we weren't able to contain them,and they were showing up

5

on the site anyway.

6

of the people got a citation which was very much like a

So we had this

and that night one

8

The
ticket and when they went to court that was dropped.
'
next week someone called, and we got two more citations,

9

but other than that we haven't been hassled.

7

If you could go to the next couple of slides.

10
11

These are just street scenes.
SENATOR WATSON:

12

13

Tell us what we're seeing

here.

14

MR. CLARK:

15

SE~JATOR

16

MR. CLARK:

This is the needle exchange.

\'lATSON:

Is that your vehicle?

Actually, that is one of our cars.

17

But at the feet of the person -- the woman on the right

18

with the hat is dropping a syringe into a bio-hazardous

19

waste container.

20

jacket is actually giving her alcohol wipes, I believe.

21

There's a guy that's obscured behind them, he's taking

22

data and the woman over to the right is basically doing

23

what we call crowd control.

The woman on the left with the black

24

You can go to the next picture.

25

SENATOR WATSON:

So let me just ask you about

12
it.

You have three people out there?

2

MR. CLARK:

This night there were probably -At this point

3

Usually on a team there are five or six.

4

two of the team members have gone out into the street to

5

tell people in the street that the needle exchange is

6

ha

ning.

We are dealing with a group of people who are

famous for not showing up on time.

That's when you think

8

about 2100 syringes, 360 people in a two hour period, it's

9

pretty incredible that these people, who are famous for

10

not getting anywhere within two hours, show up.
SENATOR WATSON:

11

needle yourself?

They take the needle and put it into

MR. CLARK:

No, we ask them to show it, rtnd as

drop them in, we count.
t

Now, you don't touch the

So, in fact,

you can't really

these are not great photos-- but there's a
with a bio-hazardous waste container.

So, we don't

r come close to the syringes.
There's another couple of slides of this street
He e is the roving team on 6th Street.

The blo-

rdous waste container in this situation 1s over here
1

the baby buggy.

If you'll show the next slide.

SENATOR WATSON:

Are you camouflaging it,

sing it?
MR. CLARK:

Well, when we first did this our

se was to interrupt the spread of HIV, we were not

13
interested in gaining anybody's attention so we, in fact,
2

figured this was something the street people would know

3

and it wouldn't be that unusual.

4

perambulator, a dolly perambulator.

5

SENATOR WATSON:

6

MR. CLARK:

That's a 1943

That's unusual, for sure.

Yes.

So, if you show again, you can

7

see-- and if you'll show one more slide you'll get to see

8

-- the code word on the street is "we want to feed your

9

baby".

10

SENATOR WATSON:

11

MR. CLARK:

Oh, I see.

So people say, "Oh, if you want to

12

feed the baby it's right there, and you can deposit your

13

needles in there and we'll give you"

14

model is street-based,and it's based on the existing

15

Tacoma, washington model.

Basically, the

16

What we feel is that the model should be street-

17

based and that the program should supply sterile injection

18

equipment, cotton, alcohol wipes, AIDS prevention

19

information, bleach and condoms,and it should be available

20

in an non-judgmental, user-friendly environment.

21

believe that there should be no requirement for

22

participation other than the possession of a syringe and

23

the willingness to exchange.

24
25

SENATOR WATSON:
supplies?

We

Now, you supply all of these

14
MR. CLARK:

Yes.

SENATOR WATSON:
3

And that's through the

donations?
MR. CLARK:

4

Yes.

Initially, this was not -- in

5

fact,

initially up until May 24th when I was writing a

6

poster that we presented in Montreal about the exchange,
we had exchanged 4,500 syringes.

8

It looks like in the

month of November alone we're going to break 8,500.

g

SEHATOR WATSON:

So,

10

have to give one in exchange.

11

su

if you have those,

you

How do you buy your

lies in that bulk?
MR. CLARK:

12

There are only eleven states in the

13

District of Colombia that demand a prescription to buy

14

syringes and, of course, I would never do such a thing,

E,

but -- l did at one point,

6

l was an employee at the

University of California, San Francisco as a buyer of
cal supplies, so I kind of know how to do that sort of
ing, but I would never do anything like that.
SENATOR WATSON:

19

MR. CLARK:
lDJ

Of course not.

We basically reach out to the

t1on drug user as a valuable and respected

nd vidual, which is different than most people reach out
nJection drug users.

They confuse the war on drugs

w1th the war on drug users, often, and regardless of what
evaluate their choices -- Like,

I myself as a person in

15
recovery do not think using is the best thing, but I also
2

know that recovery is a process of attraction and not

3

promotion.

4

they have to be ready to move towards recovery.

one can't badger someone else into recovery;

We view addiction and substance abuse as a

5
6

social, economic and public health problem and believe its

7

solutions are to be found in a social context.

8

concern,and the most difficult thing for injection drug

9

users or for all drug users for that matter in this

our major

10

culture, is that there is no access to treatment.

We

11

always talk about just say "no", but just say no for a

12

person who is addicted is not enough.

13

early intervention among adolescents,and I think it's

14

questionable at that.

15

treatment on demand with no waiting list.

16

to treatment,but it's incredibly hard to tell somebody,

17

"Well, you can go here six or seven days, 7:00 in the

18

morning, show up dope sick and maybe you'll get in on the

19

eighth day."

It may work as an

But we believe there should be
We do referrals

Nancy, the woman who I quoted in the beginning,

20

21

talked about, I don't have her quote with me, but she

22

talks about her heroin habit as she's either well or she's

23

sick.

24

either she's sick, she needs the drug; or she's well,

25

she's gotten her fii.

In her frame work it is not about being high.

It's

So, telling someone to wait seven

16
d

I mean we tell them to show up

s and show up sick

2

si

3

treatment

because you have to demonstrate need to get into
just doesn't work.

SENATOR WATSON:

4
5

Do you do anything with

evention when you talk with them?

6

MR. CLARK:

7

view what I do in the context of 12 steps as in

8

I talk about, in the context -- I

12 step program which is "reach out to the addict that

9

still suffers" and I talk about what my process of

0

r

ery was about and talk about how I managed to stay
ars clean and sober.

11

People like to hear that;

from me often because I don't look like an exi

ection drug user.

SENATOR WATSON:

How did you come to the

ilitation process?
MR. CLARK:
luck.

I was -- in a lot of ways it was just

I didn't think I had a problem.

in denial.
NA meeti

I was pretty

I'm sort of an interested person.

I went

just to hear and sort of experience what

s like because somebody I knew was in recovery,so I
I'll go check this out.
it out.

This isn't about me, but I'll

I heard speaking at that meeting

who was about 20 years older than I am, had my
story but was speaking from 20 years down the road,
about not knowing whether or not -- knowing

17
there had been a hit and run,but not knowing whether their
2

vehicle was the one because there had been blood on their

3

bumper.
I like listened to it and said, "Oh my God, this

4

5

could be me", and I looked at my family history in which

6

there were a number of -- an Aunt of mine died in the

7

Bowery, a single-room occupancy hotel, and I said I don't

8

want to know if the end of cocaine and alcohol for me is

9

going to be there, or is it going to be like my father who

10

is sort of a nice,controlled drinker.

11

problems, gets better.

He sort of has his

I just didn't

12

SENATOR WATSOH:

13

MR. CLARK:

Addictive personality?

Yeah,

I didn't want to find out.

14

That's how it worked for me.

I basically consider myself

15

incredibly lucky because I didn't reach a bottom like a

16

lot of people have to.

17

and I was 32 at the time, and I said I'm not going to do

18

this.

I just sort of went, and I looked

I don• t want to find out.

19

SENATOR WATSON:

20

MR. CLARK:

Uhat were you ingesting?

I mostly did cocaine and alcohol.

21

Not often injecting cocaine but occasionally because as

22

the quantity of cocaine I was using was expensive,and it

23

was a more efficient means of getting high.

SENATOR WATSON:

24
25

same time?

Do you do them both at the

18

MR. CLARK:

Mostly, I would do them both at the

2

same time sort of to take the edge off.

3

take the edge off the cocaine.

4
5

SENATOR WATSON:

The alcohol would

Then more cocaine to put it

back on?

6

MR. CLARK:

Yeah, it's incredibly-- It's sort

7

of your professional's drug of choice.

8

people that you don•t know have the problem.

9

they're doing.

10

SENATOR WATSON:

11

MR. CLARK:

12

7
18
19

I do know.

Right, but you know sometimes you

SENATOR WATSON:
Yo

15
18

don't know but you can certainly see -MR. CLARK:

cou

You can tell in behavior.

tell.

I always liked to think that nobody

You know, the denial lasts even after.

So, basically what I think, you know,
iction has not worked.

The funds available for the

an/Bush -- and the article that Nadleman had in
ence is incredibly interesting.

21
22
23
24

That's what

don't know.

13

14

It's a lot of those

In 1987 alone, the

this country spent 10 billion dollars on
diction.

That's a hell of a lot of treatment.

And

that period, the price of a kilo of cocaine dropped
80 percent.

During that period also, the quality of

aine on the street went from 12 percent pure to 60

19
percent pure.
2
3

4

So, the drugs are getting better, getting

cheaper, and yet we're spending 10 billion dollars on
interdiction, and there's no money for treatment or
recovery.
So, we know that needle exchange and

5

6

distribution programs have been operating in New York

7

City; Tacoma, Washington; Boulder, Colorado; San

8

Francisco, California; vancouver, British Columbia;

9

Montreal, Quebec, Toronoto and Ontario.

Programs abroad

10

include England, Scotland, the Netherlands, Australia,

11

Sweden, Poland and Italy.

12

has been implemented, participants have reported safer

13

needle use,and there has been no evidence of increased

14

drug use.

In places where needle exchange

Syringe exchange schemes attract participants

15

16

that are not reached by other public health interventions.

17

These participants may indeed be persuaded to opt for

18

treatment, although I feel needle exchange should be

19

treatment-based, I mean treatment-linked but not treatment-

20

based.

21

mandatory that you be on a waiting list to go to

22

treatment.

23

people are being sent which some people want.

24

know how valuable a modality of treatment that is

25

substituting one opiate for another.

It should not be mandatory.

In New York it is

In New York it is methadone maintenance where
I don't

so, we don't believe

20

it should be treatment-based,but we think it should
treatment-linked.

2

3

That through needle exchange one

be able to have the option to get into any number
modalities,such as some interesting and new modalities

4

5

being developed, such as by Bayview Hunter's

6

San Francisco which is treatment that includes
symptomatic detox, or a Haight Ashbury Free

7

8

which uses clonodine patches.

Q

going on that aren't getting funded other than

10

me

So there's other

one detox.
Basically, internationally needle syringe

12

-- I was in Montreal in June.

ex

There was like

13

exchanges in non-HIV intervention.

14

the data's in.

It's not

In places as diverse as Holland

15

England,the data's in,and it's an accepted

16

rvention.

We're here sort of waiting and arguing and

izing about this issue, and I know there are people
e getting infected today.
for me.
t

I used to think I did

I'm an HIV pre-test and post-test counselor

my work, and it's really about me not having to

another person that they're HIV positive.

The

22

I ever gave a result to was to a black woman

23

r mid-30's with two children. She had been clean for
t

months, and I had to tell her that she was HIV-

itive,and I had to see her cry when she was saying, "Am

21

I going to be able to survive to see my kids live?".

I

2

don't want to have to do that anymore.

3

about somebody else, but I know it's about how I'll keep my

4

balance throughout this epidemic.

5

done everything that I could, and I want to challenge you

6

to do everything you can because there's no time to argue

7

and moralize about it.
SENATOR WATSON:

8

9

So it used to be

I'll know that I've

Are you through with the

slides?

10

MR. CLARK:

Actually there's a couple of more if

11

you want to go through them quickly.

12

the end that will end.

13

SENATOR WATSON:

14

MR. CLARK:

There's a slide at

Okay, we'll let you.

This is a team in a mission and I

15

think there's-- These are the syringes and the data, and I

16

said there's a box of alcohol wipes but there isn't, and

17

that's the whole-SENATOR WATSON:

18

19

Could we have the lights up

please?

20

Now, if you were able to design a program under

21

law, a sponsorship of government, how would you structure

22

it?

23

MR. CLARK:

In San Francisco, now I can only

24

talk about my community, I basically think it has to be

25

community-based.

22

SENATOR WATSON:
Wo
3

d you have the Public Health Department, the doctors'
fices
MR. CLARK:

4

5

Where in the community?

HOlla

No, I would have it street-based.

has locations within clinics and also out in what
call the methadone buses because they also do low-

6

threshold methadone; the ones that work are the ones that
8

ar

out in the street.
I would have it street-based.

9
10

c 1

ally appropriate, ethnically appropriate education

that gives you the outreach workers.
12

a

13

recovering.

4

I would have

I think it's

opriate to have a number of people that are

to

one thing that I think is real important is

n up access to treatment.

That when people talk

genocide; there is genocide happening in this
It is happening in the systematic denial of
recovery services,and if you don't give them
r access to recovery, a better economic opportunity,
ter social availability of the options in their lives,
y gain is going to be drugs.

So, I think you have

a lot of other stuff like giving available treatment
so giving training and opening up economic
tu ities for the people.
neve

Because, like, Nancy has

worked.

SENATOR WATSON:

How old is she?

23
MR. CLARK:

SENATOR WATSON:

2

3

32.

Holding a job?
Not as a heroin addict.

4

MR. CLARK:

5

SENATOR WATSON:

6

MR. CLARK:

8

SENATOR WATSON:

10

Does she have other

problems?

7

9

Is she capable of working?

has other problems.

I'm not a clinician.
No, but do you know if she

You said she's never worked.

Is drug

addiction a result of not working or --

11

MR. CLARK:

It's mostly drug -related.

Her not

12

working is due to her being in the "life".

13

infected although she's asymptomatic.

14

out-- she said she would never have gotten tested;

15

however, her boyfriend had been diagnosed and recently

16

died, so that's how she came to know.

17

She's also HIV-

The way she found

I think that the other thing is I would make it

18

extremely easy for the injection drug user to get tested

19

because that, as an HIV pre-and post-test counselor, I

20

l~now

21

you the motivator to change your behavior.

22

positive gives you a motivation to not infect other

23

people.

24
25

that knowing you're negative helps you change or gives
Knowing your

Also, my hesitancy about-- It's very hard for
me to say somebody, "Well, you should know that you're

24
itive because there's AZT trials going on."

But yet I

2

know that it's very hard for an injection drug user to

3

m

4

without giving them access to greater primary health care

those trials.

So, it's sort of like,

I don't know if

5

for them knowing that they're positive doesn't mean

6

they're going to get good health care.

7

So,

I would

do that.

8

So, it's increase the amount of treatment, get

9

better access to health care, have it street-based, have

10

it non-judgmental, treatment-linked,but not treatmentbased.

SENATOR WATSON:

12
13

Would you have a health care

ovider as part of it or volunteers that are paramedics?

MR. CLARK:

14

I would like to see there being some

sort of street- like, you know, there's a van, well it's
than a van, it's an RV vehicle, that Haight Ashbury
inic uses to do street triage, because often we'll
e with abscesses on the street that won't go to
emergency room because of the way they're treated 1n
ency room for an abscess, and that's really the
ace where people get medical care.
t

So, I'd like to

happen.

SENATOR TIATSON:

You want an allied health

person or a paramedical person there as part of the
ram so they can be triaged?

25
MR. CLARK:
2

professional level.

3

treated.

I'm not sure exactly of the
Yes, I think abscesses need to be

SENATOR WATSON:

4

You do probably very casual

5

triage, but you need somebody there who can say it looks

6

like you have jaundice, you know, get thee to the doctor.

7

MR. CLARK:

Exactly.

8

SENATOR WATSON: Okay.

9

MR. CLARK:

When you consider the costs of

10

treating an HIV infected person, this is a cheap

11

in terven ti on.

12

being done now in San Francisco.

13

I mean it can be done at the rate it's

SENATOR WATSON:

How are you being accepted

14

in San Francisco in terms of government and law

15

enforcement?
MR. CLARK:

16

Incredibly schizophrenic.

A little

17

bit bizarre.

The Department of Public Health, Doctor

18

Werdegar will present and speak in favor of needle

19

exchange.

The Mayor's Task Force on HIV supports needle

20

exchange.

We know that the Board of Pharmacy in the state

21

of California supports needle exchange.

22

Medical Association supports needle exchange.

23

that important public health intervention falls into the

24

hands of what could be categorized as rank amateurs.

25

have some expertise that we bring to the issue,but we

The California
But yet,

We

26
1

bring it out of our experience and our commitment, not

2

that nobody ever said I could do this, but I do it.
The police basically, because of the threat of

3
4

needle stick on the street, they're happier -- If you

5

notice between the two slides, the ones in the beginning

6

where we were showing syringes at the beginning of our

7

intervention.

8

almost entirely uncapped.

9

all of those syringes are capped and they're in much

10

tter shape.

They were incredibly funky items that were
When you look at the end almost

So, the police, the beat cop, often feels

11

that they're at less risk because if an injection drug

12

user does have a syringe it's most likely to be capped.

13

That information came mostly out of the Tacoma police

14

department, though we've had similar kinds of -- We've had

15

beat cops salute us on the streets while we're doing what

16

could be an illegal act.

17

schiz

18

19

so there's this very sort of

ic, sort of, this is a very important

tervention.

Internationally you go and you hear about

it,and then it's left to us to do.

20

SENATOR

~ATSON:

Thank you. I'm going to

have to move this along a little quicker because we're
be hi
23

MR. CLARK:

24

SENATOR WATSON:

25

Okay, right.
We do appriciate the

information that you've brought to us,and we thank you for

27

coming.
2

MR. CLARK:

Okay, thank you.
(Witness was excused.)

3
4

SENATOR WATSON:

I'd like to ask Doctor

5

Michael Smith and Mark Madsen to come up.

6

Chairperson of the Chemical Dependency Committee for the

7

California Medical Association, and Mark Madsen is the

8

Physician Education Department Manager, California Medical

9

Association.

10

11

Doctor Smith is

STATEMENT BY MICHAEL SMITH, M.D.
DOCTOR SMITH:

Thank you, Senator Watson.

I come

12

here wearing several hats today.

I suppose one of them is

13

the official hat as a member of the California Medical

14

Association, as the Chairman of the California Medical

15

Association Committee on Chemical Dependency, and as a

16

representative from the California Medical Association to

17

this hearing to present to you the California Medical

18

Association policy on clean needle and syringe exchange.

19

I also come as a physician who treats patients

20

with Acquired Immune Deficiency Syndrome, AIDS.

21

gentleman who preceded us provided an eloquent discussion

22

of some of the tragedy that we witness in dealing with

23

AIDS and some of the costs in human terms that we have and

24

we see on a daily basis in dealing with AIDS.

25

The

You and legislature know somewhat about our

28
ts, budget constraints and what goes on in the
ex

nse of caring for people and, in particular, caring

3

for

4

goi

5

tha

6

e with AIDS.

It's an enormous expense.

I'm not

to review that at this time,but the expense is more
It's time lost from work;

rsi

it's the amount of

care required; it's the shortage of hospital beds;

7

it's physician fees; it's medications that are incredibly

8

ex

nsive, and it's an ongoing process.

9
10

We, at the California Medical Association, feel
that with the policy that I will present to you in a
moment, we can reduce the risk of intravenous drug users'

12
13

igh-risk behavior.

Mark Madsen, who is here with me, is a

staff person from the CMA, and will provide for you some of
statistics that he has put together and some of the
ience from other needle exchange programs.

We need

where we, in California, are in the AIDS
where other people have been, and where we may
o

forbid.
Education, intervention and awareness in the gay
on in San Francisco and elsewhere in the state of
seems to have made a significant difference in
behavior in those groups.

We feel that the

oach can be made in the intravenous drug users,
we need to bring into this scenario one further
f

equipment, that is a needle exchange program.

29
I'm going to read to you now, if I may.
2

3

have up there a copy,and if you don't,we'd like to pass to
you now the CMA policy.

SENATOR WATSON:

4

Is it short?

5

to summarize rather than read it

6

DOCTOR SMITH:

7

You may

If you'd like

It's fairly short.

It's half a

page.

8

SENATOR WATSON:

9

DOCTOR SMITH:

Very good.
"The CMA supports needle and

1o

syringe exchange programs to reduce transmission of HIV

11

infections among intravenous drug users with the following

12

caveats:

13

be incorrectly perceived to be a complete solution, we

14

feel that it is not.

15

believes needle and syringe exchange programs are likely

16

to be effective only when part of a comprehensive approach

17

which includes,

18

opiate and stimulant users,

19

programs for hard-to-reach addicts such as was just

20

presented to you.

21

referred, but not linked to treatment.

22

be training on safer injection practices and the use of

23

bleach for sterilization.

24

these people should be counseled on safe sex and safe sex

25

practices.

Since we are concerned that such a program might

(1)

The California Medical Association

priority on treatment programs for
(2}

the use of outreach

We feel that these people should be
That there should

At the same time, we feel that

We feel that if we're going to be providing

30

i

ec ion equipment, we should be sure that we are
i

safe injection equipment.

we feel that we

ovide voluntary, confidential and anonymous HIV
4

and counseling and medical follow-up for infected

5

and their sexual partners.

We feel there should

idential counseling, testing and appropriate
7

tment programs in jails and prisons as another source

8

of frequent IV drug use.

9

services to support families of the HIV-infected drug

10

We feel there should be social

s, and we feel that this program should be evaluated on
ongoing basis.

we feel that community, both particular

ommunities that are involved and the community at large,
be involved in decisions as how this program will
arried out."
There are studies, as I mentioned, which Mark
esent.

I'll ask him to speak at this point and

o a brief summary when he's through.
STATEMENT BY MARK MADSEN
MR. MADSEN:

Thank you for having me here,

Watson and members of the Committee.

Let me

u, if I just might momentarily, the packet of
on I gave you.

The first one which holds

ing is the AIDS Advisory,and if you'll notice the
was July 1989 that that was published.

That was

oximately two years of really looking at the

31
issue and seeing where the literature was taking us and
2

what kinds of results we're seeing from the programs going

3

on, some underground and some condoned by government.

4

The needle exchange policy which Doctor Smith

5

has just read to you comes next.

6

the council in November of this year,and I 1 ve included for

7

you the references, all of which come from the Montreal

8

International AIDS conference.

9

reproduction, but they're still readable; all of them

10
11

It was just adopted by

I'm sorry about the

showing positive results of needle exchange.
I also included for you on the buff paper the

12

San Francisco Medical society's policy on needle exchange

13

as well as the AIDS Foundation.

14

editorial review of needle exchange programs throughout

15

the world by Gerry Stimson that really provides a

16

framework for understanding the whole notion behind needle

17

exchange which is somewhat -- Really we should be talking

18

about HIV prevention programs which include clean needle

19

and syringe exchange.

20

It's just one aspect of HIV prevention.

21

includes a morbidity/mortality weekly report that talks

22

about a program in Boston called Project Trust.

23

let you know that obviously the U.S. Public Health

24

Services sees needle exchange as something viable and

25

worth talking about in its mortality weekly report.

And then, an excellent

That's the basis of the CMA policy.
That also

And, to
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1

Although some of you know me as the AV
today, I come to you from CMA, having spent the

3

ars working with CMA Task Force on AIDS,

4

virtually the entire packet of policies that
its official position paper.
exchange is the latest piece to that puzzle.

The
And I

emphasize that it really is on the programs that
as important for HIV control.
g

10

I'm going to forego talking about statistics in
led way because there are many more people here
to speak,and they have a much better handle on the
istics then I do.
Let me just say a few things.

Why is it CMA

we felt it was important that CMA take a
role here to provide medical and scientific
su

rt an overall HIV prevention program which

needle exchange.

A tendency is, as we all know

, to emotionalize the issues surrounding the HIV
One of the major forces here, and we felt to be
or e, would be to provide that data and to help
onalize some of it and to help provide guidance
rams that are going on around the country,
u arly in California obviously, at the local and
ernment.
As I said, we've studied the issue for more than

33
two years.

Needle exchange is not the whole answer, just

2

part of the program.

As I said, it needs to be part of a

3

larger program.

4

California is what I would call at a window of opportunity

5

that's closing fast.

6

you,you can see what's happened in New York and New Jersey

7

where that window of opportunity has closed.

8

out somewhere with a five to fifteen percent HIV infection

9

rate among IV drug users,and it increased to 30, 40, 50

The state of HIV infection now in

In the literature that I've given

It's now at 70 percent.

They started

10

percent.

There is no program for

11

needle exchange there that's going to have a big impact

12

like it can in California.

13

window of opportunity.

We are now looking at the

Doctor Werdegar, I'm sure, will talk about

14

15

statistics in San Francisco, but in the beginning we saw

16

somewhere less than five percent infected,and now we're up

17

to somewhere around 15 to 17 percent infected.

18

know that we ever got data out of New York City that

19

showed something less than five percent.

20

started to look, it was around 15 to 20 percent.

21

where we are right now.

22

We've been able to follow, and in San Francisco

23

particularly, the statistics on who has been getting

24

infected.

25

I don't

The moment we
That's

We've got a good look at it.

Most importantly, I think, the people who are

34
1

to be affected by a comprehensive program are the

g i
l

ers, the sexual partners, the children of IV drug users,
become infected during that time when an IV drug

3
4

user was not considering recovery as an opportunity for

5

them

That really is the key issue and that is providing

6

an

rtunity.
You cannot communicate with these groups of

7

e, IV drug users, in the same way that you do with

8

9

the

rson who is looking to buy an automobile or looking

10

to find out what politics are going on in the state.

11

d

12

read Time Magazine.
TV maybe.

They don't watch TV.

Late

They oftentimes don't have TV's.

to be a way of communicating with them.

They

There

We feel the

exchange program is the incentive to get them to
to offer them opportunities,and that's really the
the CMA policy today.

SENATOR WATSON:
policy.

Well, let me just ask you

Would CMA support the syringes being

thout a prescription?
MR. MADSEN:

That's a specific question.

Sold?

l cy talks about needle exchange, not someone coming
buying a syringe, off the street wanting to buy a
we feel it's important that exchange be a part
You need to be able to demonstrate that you're
a needle.

we certainly wouldn't want to be

35

misperceived that someone could come in and buy, for fear
2

that we might get sort of an attitude that somebody is

3

just experimenting with drugs, they could just come in and

4

buy a needle.

5

policy.

I don't think that's what we meant by the

6

Doctor Smith you might like to comment.

7

DOCTOR SMITH:

Well, I think that's part of it.

8

The other part of it is that we want to intervene with

9

these people at each time that we see them and that

10

intervention doesn't have to be "we're taking you off the

11

treatment"; that intervention can be you're using cleaner

12

techniques, you're cleaning up your act, you're getting

13

your life together.

14

be at whatever level we decide is appropriate on the

15

street; most importantly people who are "12 stepping",

16

people who have been there and are now getting well or who

17

are on the road to recovery and who can say to the

18

addicts, "I've been where you are, I've walked in your

19

shoes, now walk with me."; and that's effective.

20

necessarily effective the first time you see the person;

21

it may be effective after a couple of months of trust.

22
23

You use the counselors,and they can

SENATOR WATSON:

It isn't

It's like the alchoholic

anonymous mode.

24

DOCTOR SMITH:

25

SENATOR WATSON:

Absolutely the same thing.

Okay, let me ask you

36

ng about this particular advisory position.

It

this advisory group has prompted city public
authorities to announce that they will go to the
4

state and seek permission to institute a program of needle

5

ex

6

cone

7
8

How committed is CMA to that proposal, that
?

licy
adv

9

Would CMA, if such a bill were introduced, a
oposed, would CMA be willing to come and be an

ate and lobby us for that particular policy?
MR. MADSEN:

Yes, they would, and that's exactly

nted to set the foundation and the framework with
the

2
13

le n needle exchange policy program.

SENATOR WATSON:
se li

So, you're not talking about

needles so we'll drop that piece off.
MR. MADSEN:

That's a very specific kind of

If a program was developed and a component of it
es were sold and there somehow was an
10n model, it wasn't just selling needles, then
y would have to look at that and evaluate that and
it to our policy.

WATSON:
MR. MADSEN:

I just threw that out.

Let me just give you a couple of

cs that I think nobody else is going to mention
That was part of the California Department of
Services family of surveys they conducted in 1987
lowed up in 1988, revealed some startling

37

statistics.

128,000 adult Californians reported needle

2

use during some time in their lives.

3

needle use during

SENATOR WATSON:

4

MR. MADSEN:

5

45,000 reported

Illegal use?

Illegal use, needle use, IV drug

45,000 reported needle use during the last 12 months

6

use.

7

and 30,000 reported needle use during the last 30 days.

SENATOR WATSON:

8
9

These are all potential

persons with AIDS?
MR. MADSEN:

10

All potential with HIV infection

11

and the ability to pass it on through their sexual

12

partners

13

SENATOR WATSON:

Do you know of this 28,000

14

adults who have used, if there's any number that shows

15

those have been identified as having HIV?

16

MR. MADSEN:

No.

17

DOCTOR SMITH:

18

SENATOR WATSON:

19

MR. MADSEN:

Senator Watson, that was 128,000.
Yes, 128,000.

No, in order to conduct a survey of

20

this kind there has to be complete confidentiality and

21

anonymous,and so there's no way to ascertain other data

22

that you might want to know.

23

SENATOR WATSON:

24

MR. MADSEN:

25

This is high-risk behavior.

It's high-risk behavior.

Then

let's look at 191,000 women having had at least one IV

38

dr

~using

sexual partner sometime during 1987.

We also

e 32,000 men having had sex with a partner who used IV
drug use.

I'll just close with one statement which I've

4

5

So you can see we begin the progression.

I can't help but say it at a time

heard and I've adopted.

ike this and that is, "Just say no"

6

l i k e " Have a n ice day"

7

i

8

doesn't work.

5

9

SENATOR WATSON:

to the IV drug user

to the c 1 in i c a 11 y de pre s sed •

It

I think we all picked up on

a ly on.
All right, did you want to conclude, Doctor

11

12

Smith?
DOCTOR SMITH:

13

4

Well, I just want to say that in

studies that have been done and we have reviewed,
e are four facts that have come out.

(l)

programs do not increase IV drug use,
se re

Needle
(2)

they do

rrals and stays at treatment programs, (3)

there is a theoretical reduction in the risk of HIV
which has not yet been borne out by the long
5

h

ies

and

(4)

that there is a definite reduction

h-risk behaviors.

They use clean needles, or they

their needles or they don't share their needles.
facts are proven in studies.

SENATOR WATSON:
DOCTOR SMITH:

You got your point over.
Thank you.

39

SENATOR WATSON:

I certainly thank the two of

,and I am very pleased to know that CMA has looked at

2
3

the issue, has researched it, and has taken a position.

4

want you to be ready to be called on because I think that

5

this is going to grow.

6

program, because of the statistics, Mr. Madsen, that you

7

just gave.

8

I would expect that a very high percentage of the 128,000

I see it as a desperately needed

We don't even know who in this population, but

and the 191,000 are potential HIV positive.
1

o for

I

So, thank you

work you've done,and we'll be in touch with you at

another time.
12
13

4
15

MR. MADSEN:

I just want to let the audience

know that I'm going to put packets of information over
here for their use.

SENATOR

~ATSO~:

Very good.
(Witnesses were excused.)

16

SENATOR

WATSO~:

Doctor Werdegar, who is the

8

Director of the Public Health Department, City and County

g

of San Francisco.

20
2
22
23

STATEMENT BY DOCTOR DAVID WERDEGAR
DOCTOR WERDEGAR:

Senator Watson, thank you very

much for holding these hearings and for inviting me to
ticipate.

I'm going to share my brief presentation

ith Doctor Patricia Evans who is the Associate Medical
25

Director for AIDS office.

Doctor Evans is a pediatrician

40

and AIDS expert.
SENATOR WATSON:
DOCTOR EVANS:

3

6

Thank you.

DOCTOR WERDEGAR:

4

5

Doctor Evans, welcome.

a r

t prepared by Doctor Evans for our San Francisco

Health Commission.
SENATOR WATSON:

8
9

10
11

2
13

In my testimony I've attached

DOCTOR WERDEGAR:
SENATOR WATSON:

Do we have a copy of that?
I have them here.
Okay, can I get one of the

sergeants to pick them up, please?
DOCTOR WERDEGAR:

In this report Doctor Evans

summarized the world's scientific literature
ints out as previous speakers have that the weight
tific evidence shows that needle exchange
, when part of a comprehensive drug abuse and AIDS
ram, are effective, that they cause no
ncrease in substance abuse, and are really
for AIDS prevention.
Yo

asked earlier and I'll just say

cally, "How are needles disposed of? 11

•

They

sed of the way hospital infectious wastes
of which, in most communities, is by
In California there are special rules for
sing of infectious waste.
SENATOR WATSON:

Have they ever considered
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1

recycling?
DOCTOR WERDEGAR:

2
3
4

SENATOR WATSON:

DOCTOR WERDEGAR:

SENATOR WATSON:

DOCTOR WERDEGAR:

17
18

SENATOR WATSON:

What do they do with the

They are reduced to ashes

What do they do with the

ashes?
DOCTOR WERDEGAR:

The ashes can be safely put

into ground fill or whatever after it's been-- well, once
it's been reduced to ash you've got a safe product to
dispose of.
These are the some of the points that I want to

19

20

Yes, the best way is just to

eventually.

15
16

heat will kill

waste?

13
14

i~~ense

be rid of them and use new products.

11

12

The

all the germs?

9
10

The

simplest way is really to ensure they're --

7

8

No,

because they're filled with blood and other things.

5
6

Recycling the needles?

make.

As the head of the Health Department in San

Francisco for the last five years, I direct health
21

22

activities in our community that has the worst AIDS
epidemic in the country.

23
24
25

We not only fight the AIDS

epidemic,but simultaneously,the drug abuse epidemic,and
simultaneously, what .I call the epidemic of people who have
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1

i

te insurance or no access to primary care.

2

three

idemics are very much intertwined.

Those

The needle exchange program is just part of an

3

4

over all program.

When it's a stand alone, there are many

5

criticisms,but when it's part of a comprehensive program,

6

it's very hel

7

clock is ticking, and we know from epidemiological studies

8

that in East Coast communities,IV drug abuse, AIDS, has

9

spread very rapidly so that in the IV drug abuse community

ul.

My concern really has been that the

10

in New York City, Newark, New Jersey, two-thirds of IV

11

drug users are already HIV positive and that their

12

partners are infected and their children are born infected,

13

and it's really a social disaster.

14

California, the rates of HIV among IV drug users is still

15

relatively low.

16

around five percent.

7

as h gh

The fact is that in

In the Los Angeles area the figures are
In San Francisco, I'm sorry to say,

s 15 to 20 percent.

These are not like the

18

Ea tern figures,and we have a chance to do something about

i9

it,and we need very vigorous programs that include all of
the things that have been described by Mr. Clark, by the
evious speakers from the CMA, and which you'll hear more
abou .

23

If we had a vigorous program and that includes

24

exchange, bleach outreach, access to health care,

25

s to dr

treatment, we have a chance to do something
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about the epidemic.
Another point I want to make -- So, time is of

2
3
4

the essence, and that means that legislative time is of the
essence.
Another point I want to make is this--,very

5
6

simply, that right now if we had utter unanimity, if

7

everybody agreed that having needle exchange programs was

8

beneficial for health, social welfare and for our

9

community, there is no mechanism up in San Francisco for

10

authorizing pilot needle exchange programs.

11

Health Director, legal counsel says the State Health

12

Director is not empowered to authorize and approve such

13

programs.

14

from Mr. Cavanaugh when he speaks for the State Board of

15

Pharmacy.

15

discussions.

17

concept of needle exchange as part of a comprehensive

18

program unanimously, and their legal counsel again said

19

that they are not empowered to authorize pilot needle

20

exchange programs, any kind of needle exchange programs.

Legal counsel says the same.

The State

You'll hear this

I testify at their hearings and heard their
The State Board of Pharmacy endorsed the

21

So, we have no agency of government in

22

Sacramento that can authorize such programs and make them

23

legal so that health departments like my own could conduct

24

them.

25

the work of Mr. Clark and his group and what they have

We would conduct street-based programs.

We admire

44
1

done.

2

much I admire their work and what I think it is doing

3

positively for our community.

4

our department, cannot initiate such programs because we

5

need permission from Sacramento,and nobody in Sacramento

6

can give it to us.

7

I have talked to our police chief and told him how

But I as a health director,

So, even if the legislature did not decide

8

whether the needle exchange is of benefit or not, well the

9

government need not decide if it's of benefit or not, I

10

think at a minimum what the legislature has to decide is

11

that there should be some respected agency of government,

12

the department of health or the pharmacy board that could

13

have the authorization to review the proposed pilot needle

14

exchange programs, evaluate them,and make them legal.

15

the moment,we have no mechanism to do that.

At

16

That, in a sense, is my bottom line.

17

our health commission very carefully reviewed this whole

18

issue.

19

the San Francisco Health Commission said that they want to

20

go ahead with pilot needle programs as soon as they become

21

legal, and they, in fact, urged that I, as the Director and

22

our Mayor and Board of Supervisors, seek what help we

23

could from the state legislature to make such programs

24

legal.

25

with all of its very pertinent "whereas's" in the

Because

We had scientific testimony, public testimony, and

I've attached a beautifully written resolution
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testimony from the San Francisco Health Commission.
2

One of our commissioners, and your staff asked

3

me about this, one of our Commissioners, Commissioner

4

Gray, was against the program.

5

-- I have high respect for Commissioner Gray.

6

loyal to her causes and her community.

7

concern was that if we had needle exchange programs,that

8

right now they're not legal, and in a memo that she wrote,

9

and I believe you and your staff have copies, you'll see

I guess my comment briefly
She is

Her principal

10

that one of her principal concerns related to the legality

11

of such programs.

12

because we had state authorization to conduct them, 90

13

percent of her concerns would go away.

I think if we had legal programs,

There was no question that she was also

14
15

concerned about the views in some of the black churches

16

that needle exchange might be viewed by the community as

17

condoning the use of drugs.

18

it's an education process working with the black ministry

19

and the black churches, is that actually the availability

20

of needle exchange programs in the long run does the

21

opposite.

22

new avenues for access to drug treatment; new ways of

23

saying to the drug addict, "We care about you and want to

24

take care of you, " and in that sense it really doesn't

25

encourage or condone; it provides a way of offering

The answer, of course, and

It opens new avenues for access to health care;
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1

relief.

I think we have to work with the black churches,

2

the black ministries.

3

to reach into the community,and we have been involved in

4

dialogue with the churches on just this point.

It's very important if we're going

So that's the gist of my testimony.

5

Most of it

6

is written.

I would emphasize that the weight of

7

scientific evidence certainly now favors the needle

8

exchange for AIDS prevention.

9

proof absolutely conclusive?".

Some have said, "Is the
In science the proof of

10

anything being absolutely conclusive takes a long, long

11

time and we don't have the luxury of a long, long time.

12

The weight of evidence, there's no question where that is.

13

Time is of the essence.

14

percent prevalence rate; they've got a 65 to 70 percent

15

rate on the East Coast.

16

suffering and social disaster if we act quickly.

17

min

18

re

19

the Health Department or the Pharmacy Board, or some

20

committee that includes those two and the University of

We've got a five to fifteen

We can spare a lot of grief and

, the legislative help we need is to give to some
ted agency of government, whether it's one agency,

ifornia, but we need some agency up there that can say

21

11

22

"ok

23

there's a proper way evaluate it.

24
25

At a

to a pilot program if it's designed properly and if

SENATOR WATSON:
p lot

Let me ask you this.

Of a

ograrn you'd have to have an evaluation, pre-and

47
post-testing.

DOCTOR WERDEGAR:

2
3

SENATOR WATSON:

5

Okay, very good.

STATEMENT BY DOCTOR PATRICIA EVANS

6

DOCTOR EVANS:

I'll skip to that and go

immediately to that.

8
9

I'm going to ask Doctor Evans

to tell you about that.

4

7

How would you set that up?

My name is Doctor Patricia Evans and it is a
pleasure to be before you again, Senator Watson.

It's

10

been awhile, but I'm pleased to be here and honored also.

11

In terms of evaluation, I have for you here an

12

example of a protocol which certainly could be used.

This

13

is a scientific protocol which was pulled together by

14

myself at the request of Doctor Werdegar, and I've also

15

received some input from some of the researchers who are

16

involved with intravenous drug users in the San Francisco

17

area; so I'll pass this out.

18

In terms of the research questions, you really

19

need to look at what specifically are you interested in,

20

because that will determine what the cost of the program

21

is.

22

researchers in San Francisco have indicated that there's

23

about a three percent seroconversion rate per year amongst

24

intravenous drug users.

25

exchange effects that you're going to have to have an

In San Francisco, Doctor Werdegar's and other

If you want to prove the needle
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1

extremely large sample size which is going to increase the

2

cost of the program.

3

We do know the evaluations from around the world,

4

as well as here in the United States,have looked at self-

5

report behavior change,and so we certainly can look at

6

those particular parameters, and that becomes less costly

7

than just looking at HIV seroprevalence and seroconversion

8

rates.

9

We can also look at secondary data set analyses

10

of other parameters such as, hospital admissions for

11

bacterial endocarditis for intravenous drug users,

12

admissions for abscesses in terms of intravenous drug

13

users as well.

14

research questions you want to ask as to which is the best

15

way to set up.

16

will really look at behavior change over time -- between

17

time one, t

18

so it really depends upon what sort of

I think that what I have provided to you

two, time three and time four --

SENATOR WATSON:

Well, one of the things that

19

we'd be interested in seeing is if our needle exchange

20

program is working for an individual; does that individual

21

test HIV positive?

22

DOCTOR EVANS:

The test should certainly be

23

offered to anyone coming into the program,and what I have

24

proposed there is that anyone who does participate in the

25

evaluation -- because I think there is a difference

49
between participating in the evaluation component versus
2

those who are in the program exchanging needles.

You need

3

to take a random sample of those participating in the program

4

to really do a good evaluation.

5

should be offered to them.

6

be coerced to take the test, though.

7

SENATOR WATSON:

HIV antibody testing

Individual people should not

See, our opponents, and I

8

was just reading the letter here, feel that in some way

9

it's making illegal activities or promoting illegal

10

activities.

11

to making the use of drugs or preventing the use of drugs

12

or making them legal if you're going to make the exchange

13

program legal.

14

In Ms. Gray's letter there's some reference

DOCTOR WERDEGAR:

Well, as you know, I talked to

15

Commissioner Gray on this point quite a bit as has Pat,

16

because at the moment there is no way at the Health

17

Department, she's one of our Health Commissioners,

18

conducting the program legally because we have no way of

19

getting the authorization from any agency of state

20

government; she feels that exchanging needles encourages

21

people to engage in illegal behavior.

22

that I think 90 percent, maybe not all, of Commissioner

23

Naomi Gray's objections are solved by our being able to

24

put such programs on a legal footing by having appropriate

25

authorization to the Health Department.

That's why I said
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SENATOR WATSON:

1

And I think one of the ways

2

of doing that is by showing some data that says that it

3

does have a positive effect, at least this percentage

4

has not developed HIV yet.

5

DOCTOR EVANS:

That's correct.

The other thing,

6

too, is that we are always following the cart before the

7

horse, it seems, because everyone -- the arguments that I

8

get are that needle exchange has not been proven, but how

9

do you ever prove it unless you evaluate the program?

So

10

you need to evaluate the program so you can say if it is

11

or is not effective.
We do know that it is effective in terms of

12
13

positive behavior change.

14

from around the world.

15

in the United States.

16

the program up in Tacoma, as well as the program in New

17

York City, but we need to evaluate other programs as well,

18

too.

19

That information is available

It has also become available here
Don DesJarlais, who is evaluating

The other thing that I'd like to point out is

20

the fact that instead of talking about needle exchange as

21

a needle exchange, you really need to talk about it as

22

another form of outreach because that's how I really see

23

needle exchange.

24

to reach a group of individuals who have been difficult

25

for the current system to reach.

It is another form of outreach activity,

It's really our problem
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that we cannot reach them.
2

problems.

3

out to them.

4

It is not they who have

It's really us who have the problems reaching

This is another form of outreach,and literature

5

certainly does indicate that a number of people, and in

6

fact, there was a study in England that shows there was

7

about a third of those who participated in the needle

8

exchange had never been in contact with the substance

9

abuse treatment programs in that country.

So, again, we

10

have access to a patient population which we currently do

11

not have access to and we won't be able to give any

12

messages to no matter what we do, unless we try different

13

forms of outreach.

14

like to get across.

15

so that's another point that I would

The other thing is that you talked about needle

16

exchange in terms of what it should really look like.

17

And, again, if I look at it in terms of outreach, there

18

are other aspects to those outreach activities which need

19

to be included because then you can clearly see where and how

20

this outreach activity will occur.

21

about the scope of the interactions, such as discussions

22

of proper needle hygiene as well as safer sex.

23

also be a risk assessment done on individuals, not just in

24

terms of medical care, but also in terms of legal housing,

25

nutritional needs, psycho-social needs, because this can

You can also talk

There can
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1

be part of the outreach activity, as well as referrals to

2

the proper agencies which requires that those who are

3

participating in outreach, in terms of the outreach

4

workers, need to be properly trained.

5

Then there's the whole issue of advocacy that needs

6

to go on in terms of outreach activity.

Then we've also

7

talked about a comprehensive program for substance

8

abusers.

9

very last sheet also indicates what this comprehensive

I have given to you a sample protocol on the

10

program really should look like.

11

areas which I have included in there, and one of them which

12

has been discussed before is treatment on demand.

13

really talking about lots of different types of treatment

14

modality, not just methadone, but different types of

15

treatment modality for individuals.

16

about prevention of needle-associated transmission,which

7
18

There are a number of

We're

We're also talking

would include outreach activities not only for bleach and
condoms, but also for needle exchange.

19

re would also be general public educat1on

20

ause one of our biggest problems,as I see it, is the

21

fact that the public is ill-informed about the whole issue

22

of addiction and substance abuse and what we're trying to

23

do with needle exchange.

24

education, as well as provider education.

25

There needs to be general public

I, as a practicing physician, really received no
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information about substance abuse and addiction when I was
2

going through medical school.

3

what about those individuals who went before me, and even

4

after me,who still do not know that much about addiction

5

and substance abuse.

6

If I did not receive it,

Then there's the whole issue of research in

7

terms of this comprehensive program to make sure that all

8

of the components that we're talking about really do work

9

effectively.

What can be done to modify them to work more

10

effectively and efficiently,and how can we best reach the

11

populations what we're really talking about.

12

SENATOR WATSON:

13

DOCTOR EVANS:

14

SENATOR WATSON:

Okay.
So thank you very much.
Well, I want to thank you

15

for your fine work.

I mean, you've given us an outline

16

here that we can go back and take a look at and do some

17

additional research.

18

talking about this afternoon has to be handled very

19

delicately.

20

and it's a reaction that's probably shared by many.

21

sounds like an excessive program that exacerbates the

22

illegal aspects rather than programs that can help.

23

way we bridge that is to get good information out there,

24

statistical information out there, the benefit of whatever

25

research data we already have, and people speaking to it,

I think this proposal that we're all

I can see the reaction of commissioner Gray,
It

The
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credible people.

I think it will help us greatly to have

2

CMA sending their advisory bulletin out and to be talking

3

about this and to hold hearings when they have their

4

statewide convention.

5

what's going to bring this about.

6
7

To speak to the press.

So thank you for your good work.

We apprec1ate

it and it's good to see you.

8

DOCTOR EVANS:

Thank you.
(Witness was excused.)

9

SENATOR WATSON:

10
11

This is

All right, we've got to move

on a little quicker.

12

Doctor Flynn, M.D., Medical Director with the

13

university of California Davis Medical Treatment Center

14

for AIDS.
STATEMENT BY DOCTOR NEIL FLYNN

15

DOCTOR FLYNN:

16

7

think we're

Thank you, Senator Watson.

I

t to be buried in paper here.

18

SENATOR WATSON:

19

DOCTOR FLYNN:

20

SENATOR WATSON:
DOCTOR FLYNN:

Can you summarize this?
I certainly can.
That would be very helpful.
I would like to give you a

22

perspective of a medium size city, that is Sacramento,

23

where one would think that the IV drug problem and AIDS

24

problem is not that great compared to San Francisco or Los

25

Angeles.

But, I'd like to let you know that there are
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approximately 8,000 IV drug users in Sacramento, and
2
3

you're very familiar with the city of Sacramento.
Of those, about three to five percent are

4

currently infected,and you'll see on my bottom table

5

there, comparison among San Francisco, Los Angeles and

6

Sacramento for seroprevalence over the last several years.

7

The striking things are, as Doctor werdegar and Doctor

8

Evans have pointed out, that San Francisco was where we

9

are today in Sacramento about three to four years ago and

10
11

are now up to 15 to 20 percent infected level.
If one superimposes these curves on the curve of

12

New York City in the years 1978 through 1983, it is

13

identical and it ends up at 70 percent infected.

14

undergoing the same rate of spread currently in San

15

Francisco as was documented in New York City.

16

We are

There are currently programs for bleach use

17

disinfection,and what I'd like to do is give you some data

18

on 1400 IV drug users who we've interviewed in Sacramento

19

on the use of bleach and other high-risk behaviors.

20

individuals are interviewed for one hour each, one on one

21

in a private setting.

22

they are educated for that hour as they are asked

23

questions about their drug use.

24

period,they are given written materials, condoms and

25

bleach,and we pay them to come back about four months or

These

We've now done 1,400 of them,and

At the end of that time
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longer from that time.

we pay them $25.00 in order to get

2

them back, and we have currently about a 30 percent return

3

rate for requestioning.

4

The things I'd like to point out to you in the

5

second table among the high-risk behaviors are that

6

initially 70 percent of individuals obtain their needles,

7

the ones that they used when they shot up last time, from

8

either a connection or friends or peers.

9

understand that those needles are probably used,and those

10

syringes have probably been used before.

11

that fell to only 57 percent.

12

So you can

After education

It's still high.

Additionally, those who rinse their

13

paraphernalia in either bleach or liquid detergent or

14

alcohol, whatever, went from 54 percent who never used

15

I'm sorry, the second part is frequency of sharing their

16

needles

17

sharing their needles, 54 percent went to 74 percent.

18

we made progress there with an intensive educational

19

20
21

ogram.

went from never or sometimes, that is rarely
so

Some progress, but certainly not enough.
Of those who often, usually,or always share went

from 47 percent to 19 percent of the follow-up people.

22

One last point with regard to the third wave of

23

HIV infection, the first one being gay men in this state,

24

the second one being IV drug users, and the third wave

25

being their sexual partners and their children.

The
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second and third waves are potentially preventable at this
2

3

point in time.
Look at the last three entries on that table.

4

One sees that they rarely, if ever, use condoms, and that

5

behavior does not change after education.

6

like condoms.

7

That doesn't interfere with your pleasure at all, but they

8

do not use condoms, suggesting that our educational

9

efforts are ineffective in terms of condom use; and that

They do not

It's one thing to disinfect the needle.

10

once IV drug users get this virus, they will transmit it to

11

their sexual partners and their children, resulting in the

12

third wave of infection, such as has been seen already in

13

New York City where one in sixty babies born is born with

14

HI v , two perc en t of b ab i e s born .

15

I will simply summarize my recommendations and

16

say that they have been already articulated by the

17

previous speakers.

18

Sacramento, after two years of studying this issue have

19

felt some basic components of needle and syringe exchange

20

to be,and we agree with others that it should be only a

21

part of a very comprehensive and very well-funded program

22

for prevention of HIV spread.

23

You have a list there of what we, in

I would like to also state that while I agree

24

with the previous speakers on not necessarily linking, but

25

making available drug treatment for people in these
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1

programs, the issues of AIDS spread, HIV spread and drug

2

addiction must be separated in our minds.

3

something immediately about the spread of HIV for

4

relatively little money.

5

expect to do very much about IV drug use.

6

the process, but these two issues must be separated in our

7

minds.

8

of needle exchange fail to do in their minds.

9

it's okay, apparently, if IV drug users get the virus so

I

we can do

We cannot at the same time
We can begin

think this is one of things that our opponents
To them

10

long as we don't do anything to condone or make the

11

appearance of condoning IV drug use.

12

separated.

13

to be tied to success in drug treatment.

Those issues must be

AIDS is too large an issue and too important

Finally, I'll give you a summary of the

14
15

objections that our task force came up with.

16

the others have said, it is currently illegal.

17

law enforcement agencies, I think, would accept the fact

18

of it becomi

19

adamantly

20

para

21

programs.

22

legal and would support us.

They are as
One of our

The other is

ainst the legalization of possession of

rnalia or of legalization of needle exchange

Secondly, the wrong message, and I think we have

23

alot to do in the way that we phrase these programs with

24

whether the wrong message gets out or not, whether it's

25

seen as condoning drug use or not, we can phrase these
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programs in such a way that they actually contribute both
2

perceptually and actually on the street to decrease drug

3

abuse and increase drug treatments.

4

Finally, that there is no evidence currently

5

that these programs will increase either drug use or make

6

it more difficult for law enforcement to prosecute for

7

illegal use of drugs.

8

enforcement will lose a tool, that is, the criminal

9

possession of paraphernalia law

Another objection has been that law

is a tool for law

10

enforcement for bringing in a drug user,and our law

11

enforcement people do not use it as a tool.

12

told us that it would not result in fewer arrests for

13

illegal drug use if they were deprived of the illegal

14

possession statute.

15

SENATOR WATSON:

They have

There are certainly a lot of

16

safeguards that would be part of any public policy and

17

just so that we can enforce laws and so we can keep down

18

the growth so that we can prevent -- So all of these areas

19

will take separate kinds of safeguards,so that we're not

20

creating a larger problem than we're trying to solve.

21

DOCTOR FLYNN:

22

SENATOR WATSON:

23

And I think it can be done.
Thank you so much for coming.

Did you conclude?

24

DOCTOR FLYNN:

25

SENATOR WATSON:

Yes.
Thank you so much and we
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1

appreciate the paperwork you've given us.

2

(Witness was excused.)

3

Cavanaugh, State Board of Pharmacy and

4

, In er-Agency Drug Abuse Recovery Programs.

5

STATEMENT BY JAY CAVANAUGH

6

MR. CAVANAUGH:

7

Jay Cavan

8

our

Good afternoon, Senator. I'm

from the California State Board of Pharmacy and
President, Glenn Yokohama is kind enough to join us.

9

I'm really thrilled that we have an opportunity

10

to t

k wi

11

Board of Pharmacy in 1988 reviewed some of the problems

12

about hypodermics,and at that time,the Board felt, for a

13

number of reasons, didn't want to move ahead on any

14

recommendations for needle exchange.

15

reasons at that time were the information that we had been

16

given was that this was primarily an East Coast problem,

17

and we

18

abuse.

The two major

se are legitimate reasons.
I

a

intervening year, however, the Board went
wed the issue scientifically.

21

I remember

rsonally over 200 scientific papers, some 3,000

22

ng

23

but we wan

24

important when people's lives are at stake.

25

California

raid of sending the wrong message on drug

r

19

20

you about this important issue.

I mean talk about getting snowed with paper,
to find out the truth.

Truth is very

One of the things we saw was that we tracked the
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1

outbreak of AIDS and intravenous drug users, not just in

2

New York City, but outbreaks of AIDS in Stockholm, in

3

Milan, Italy, in Bangkok, Thailand, in Edinborough and in

4

other places, so the idea that it can't happen here just

5

wasn't so.

6

It just hadn't happened here yet.
The other thing was, and I was persuaded to this

7

because I'm an anti-drug person.

I'm an appointee of

8

Governor George Deukmejian,and I've spent 20 years

9

fighting substance abuse, but I was persuaded that the

10

posturing of being anti-drug is no longer important.

11

primary victim of the intravenous drug user who has AIDS

12

is their child.

13

The

Scientifically, there is no debate over whether

14

we should have needle exchange.

15

Organization, California Medical Association, California

16

Board of Pharmacy, State Department of Health, on down the

17

line, scientifically support needle exchange.

18

The World Health

The problem has not been a scientific one; it's

19

been a moral question,and the moral question that I wish

20

to raise, because everyone's danced around it and I'm

21

going to address it very directly and that is, that the

22

primary victims are the newborn infants of infected

23

mothers.

24

to avoid giving a pro-drug message we will allow these

25

people to suffer?

On what moral grounds can we say that in order

It's not supportable.

It's a
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1

fundamental ethical question.

2

That question was raised and presented in the

3

Montreal International AIDS conference,and it certainly

4

persuaded me.

5

drugs or continue to use needles.

I don't want to suggest that anybody use

I know also that the scientific evidence showed

6
7

four key points and these are them, mentioned before but I

8

want to reiterate them because they're important that they

g

be on the record;

(1)

Needle exchange programs as part of

10

an overall AIDS education and drug treatment effort

11

reduced the spread of HIV, reduced the degree of needle

12

sharing, did not result in any increase in people abusing

13

drugs intravenously -SENATOR WATSON:

14

15

done?
DOCTOR CAVANAUGH:

16
17

done from a

WATSON:
DOCTOR CAVANAUGH:

19

in

land.

Oh, this research has been

oximately 1984 through 1989.

18

20

Where was this research

And where did it take place?
In England, a great deal of

A great deal of it in Australia.

You know

21

Australia has needle exchange throughout the entire

22

country

23

it in the pharmacy.

24
25

whole country has needle exchange.

SENATOR WATSON:
in terms of AIDS?

They do

What's their growth pattern
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DOCTOR CAVANAUGH:
2
3
4

5

have stopped it cold.

They have stopped AIDS.

They

They stopped it dead in its tracks.

The same thing in England.

Now in Edinborough they had an

outbreak,but in the balance of Great Britain they were
able to halt this geometric increase.

6

You see, what happens, and it was eluded to

7

earlier, the increase goes five percent, ten percent,

8

fifteen percent and somewhere between fifteen and twenty

9

percent, when fifteen to twenty percent of the intravenous

10

drug users have the virus, right around there,a geometric

11

curve cuts in and it skyrockets.

12

prevent that increase in England.

13

prevent it in Denmark, in Australia and in other areas

14

where they implemented, not just needle exchange, but

15

comprehensive efforts that included needle exchange

16

programs.

17

been done throughout the world.

18

been published.

19

importantly, in every study that I read there was an

20

increased number of individuals referred to drug abuse

21

22

Now they were able to
They were able to

We're at that point here,so the research has
Many, many papers have

No increase in drug abuse and most

trea trnent.
Now, if you're anti-drug and you want people to

23

stop using drugs, how can one not support something that

24

gets more people the help that they need?

25

the Board reconsidered.

On that basis,

We held our own hearings this
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year.

Those hearings included many of the same witnesses

1

2
3

that you heard and many others.

We reviewed many of the

scientific papers and on a unanimous motion, the State
Board of Pharmacy agreed to support a pilot needle

4

exchange effort as part of an overall AIDS education and
5
6

drug treatment program.
The reason we put those caveats on it is we

7

8
9
10

don ' t want to go will y n i 11 y saying , " Let ' s just hand out
syringes to people"; we want to do this in a responsible
way.
That's basically my presentation.

11

12

want to add something?
MR.

13

14

15
16
17

18
19

20
21

22

25

YOKOHAMA:

No, I wasn't going to add

anything other than some of the speakers had mentioned, I
guess, the Board of Pharmacy is looking for, I guess
there's a co

e of avenues of going, apparently.

those avenues is

One of

legislature telling the Board of

Pharmacy or the Department of Health Services that you are
the ones

t w l l be charged for evaluating pilot

programs, for example, and I guess the other one is just
through the legislative process where you get legislation
to --

WATSON:

23
24

Glenn, do you

Okay, let me just ask --I

thought I heard you, Mr. Cavanaugh, say that the
Department o

Health Services was in support of the needle
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exchange program?
MR. CAVANAUGH:

2

Yes, I read an interim report

3

that was presented to Ken Kizer wherein they stated

4

clearly that they were in support of a pilot program.

5

see, there are public and private positions that are being

6

taken.
SENATOR WATSON:

7

Was it just a needle

8

exchange or the AIDS Leadership Plan that they were in

9

support of?
MR. CAVANAUGH:

10
11
12

You

Needle exchange was part of the

report.
SENATOR WATSON:

13

overall comprehensive --

14

MR. CAVANAUGH:

They were in support of that

Yes, and in private

15

conversations with folks, they do support it.

16

basically saying, to let the cat out of the bag, is how do

17

we do this in a way so that we don't get creamed

18

politically?

19

starting to tell the truth.

20

support a needle exchange program that is done with the

21

proper safeguards,and I think other conservatives-- I

22

mean, after all, what's a conservative if you can't

23

conserve life?

24

will help prevent these newborns from getting this virus.

25

What they're

And I believe that the way to do it is by
I'm a conservative, and I can

And we have to support any effort that

SENATOR WATSON:

Are you clear whether the
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Department supports the provisions of this plan or do they
1

2

just support the report from the Advisory Committee?
MR. CAVANAUGH:

They supported the report from

3
4

the Advisory Committee.
SENATOR WATSON:

5
6
7

8

Okay, so we would have to

then find out if they support -- I had heard that they
were opposed to a needle exchange program, but maybe with
this kind of comprehensive approach?
MR. CAVANAUGH:

I think what's happening, what

9
10
11

12
13

14
15

we're seeing here today, there is a consensus building in
the professional community.

Medical Association, California Board of Pharmacy,
responsible, basically conservative organizations, saying
please grant us the authority to oversee such programs in
a responsible way, then that has to have some effect.
SENATOR WATSON:

16

17
18

19

20

23
24
25

I

don't even know what

conservative means when you are addressing this issue,
when

u say

u're a conservative.

You've got to break it down for me.
r

t

That has no meaning.
I think you're on the

road.
MR. CAVANAUGH:

21

22

When you have California

e,

It means that I care about

it means that this is a public health issue to

me, not a political issue.
SENATOR WATSON:

Well, throw away the use of

conservative because I don't think it describes anything.
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MR. CAVANAUGH:

Yes, but the opposition to this

2

plan is going to be a dogmatic one in my mind, and it must

3

be overcome.

4

SENATOR WATSON:

And, they will present the

5

moral arguments,and they have a place somewhere over here

6

while we address what's actually happening today with

7

human beings.

8

argue it based on what we see is occurring among people

9

within the society, and what is our responsibility to

10

11

we can argue this morally, but we have to

address from the health stand point.
MR. CAVANAUGH:

Yes, and senator, one point that

12

hasn't been made.

13

and from everything we know,an addiction really is a

14

disease,and the intravenous drug user has, over the course

15

of time, diminished ability to exercise sound judgment.

16

Education in these cases, as Doctor Flynn points out, will

17

not necessarily work.

We cannot prevent these people from

18

continuing their use.

Now if they were the sole victims,

19

morally you might say they made that initial choice;

20

they're entitled to it.

21

their children, and the members of the community, we're

22

condemning those people to getting the virus, and there is

23

no moral standing to do that.

24

25

Addiction, I'm a molecular biologist,

SENATOR WATSON:

But their sexual partners,

I think that your Board

could do a lot for society by promoting and saying just
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what you said here.
2

3
4

5
6
7

10
11

12
13

14

15
16
17

18

19
20
21

22

23
24
25

I

think from the appointing power, you're there because they
felt that you could present the case in a rational,
reasonable, logical way; so do it.

The more you speak out

and the more you show the results of your research and
your study and input from your advisory committee the
easier it is going to be.
You see, on the other side of a conservative is

8
9

I think you have credibility.

a lioeral, and that's me.

The easier it's going to be for

me to propose such a program.

If we get it blocked up at

the top, and I think you're going to understand what I'm
talking about, then we've just had an afternoon exchanging
ideas.

I want this to turn into something real and

certainly your Board can help.
MR. CAVANAUGH:
MR. YOKOHAMA:

Oh, it must.
By the way, I was going to say,

Senator Watson, that the pharmacists, the CPAC as well as
the California Society of Pharmacists, does have a task
force that is trying to promote within the profession as
well as in the community, some of the message that you
ke about.

SENATOR WATSON:

I would like to invite all

of you here, and particularly you two,

I have a health

advisory committee that's been ongoing for about 14 years
now,and we've broken up into task forces.

We have not
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looked at needle exchange.

We've looked at substance

2

abuse as a whole,but I think, Jane, we should have one

3

meeting dealing with just this issue because it's a cross

4

section of all health providers and not only health

5

providers,but third party payers, and all those who are

6

interested in health delivery systems here in the state of

7

California;

8

to grow in terms of its visibility and our attention to

9

it.

10

and I feel that this is an area that is going

MR. CAVANAUGH:

I believe, Senator, the Board

11

would support a bill that empowered the State Department

12

of Health or the Board of Pharmacy --

13

14

SENATOR WATSON:

Would you write me a letter

to that extent?

15

MR. CAVANAUGH:

16

SENATOR WATSON:

17

MR. YOKOHAMA:

Sure, yes we will.
Thank you very much.
Thank you for the opportunity.

18

Also, I'm not sure if it would be useful, but we do have

19

the minutes of the last meeting.

20

SENATOR WATSON:

21

MR. YOKOHAMA:

22

25

Thank you very much, appreciate

it very much.
(Witnesses were excused.)

23
24

Oh, we'd like to have that.

SENATOR WATSON:

I'd like to call up now the

Executive Director of the Minority AIDS Project in Los
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1

Angeles, Gil Gerald.
STATEMENT BY GIL GERALD

2

MR. GERALD:

3

SENATOR WATSON:

4

MR. GERALD:

5
6
7

8

11

12
13

14
15

18
19

20
21

the Executive Director of the Minority AIDS Project.
I have been involved for more than six years in
the response to AIDS and what is usually termed, in public
health jargon, the minority community.

24
25

Minorities, in

fact, make up or are emerging as the majority in many
urban centers.

HIV transmission through needle sharing is

a significant threat to our communities because drug use
and abuse has surpassed epidemic proportions.
In California, as has been stated, there may
till be an

rtunity to prevent the higher incidence of

HIV disease among IV drug users that has occurred in the
northeastern cities of the United States.
for this o

I

thank you

rtunity to present testimony offering support

for needle exchange programs.
Needle exchange should be instituted as part of

22

23

Senator Watson and Honorable

committee, my name is Gilberte Gerald,and I am currently

16

17

Good afternoon.

Members of the Senate Health and Human Services

9
10

Good afternoon.

a com

ehensive set of programs that are desperately

needed to combat both the HIV and drug use epidemics.
views I offer on the question of needle exchange come

The
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mainly from work on a report conducted under my direction

1

2

while I was the Director of Minority Affairs for the

3

National AIDS Network in washington, D.C.

4

this report were published in the June and July 1989 issue

5

of NAS Newsletter, multi-cultural notes on AIDS education

6

and service.

The results of

7

The report looked at a number of needle exchange

8

programs underway around the country and the public debate

9

surrounding them.

o

report reveal no significant new information.

A recent check with the sources of this
I'm

11

submitting copies of this article as part of my testimony

12

which I've provided to you.

13

Before speaking on the issues of the efficacy of

14

needle exchange programs, I would like to offer the

15

following commentary on one basic political issue posed by

16

needle exchange proposals.

17

public debate surrounding needle exchange programs is that

18

these proposals are often presented or perceived as

19

substitutes for a comprehensive set of programs that are

20

desperately needed for the intravenous drug using

21

population.

22

stage for a lot of drama.

23

by government to respond to the pent up demand, to apply

24

the necessary resources to help the individual intravenous

25

drug user and his or her family, then members of the

A major problem with the

This is a false construct which sets the
If, in fact, there is no will
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1

community, particularly the African-American community

2

will be hard pressed to understand why there is now a will

3

to fund a program that at this time can only partially

4

answer the question of whether it will stop the spread of

5

HIV.

6

In this sense, the needle exchange programs are

7

pitted against a whole set of unmet needs and are seen as

8
9

a bandaid solution to a much larger problem, the drug use
epidemic and it's root causes.
Needle exchange programs need to be viewed in

10
11

the context of the need for a comprehensive set of

12

programs in which they are but one of a whole arsenal of

13

strategies that need to be employed to deal with the HIV

14

and drug use epidemic.

15

should include

16

a full range of options beyond methadone, as well as

17
18

19

20
2

ograms

This comprehensive set of programs

ograms including treatment on demand with

oviding referral and full access to medical,

mental health, housing, job training, job placement, child
care and legal services.
In

experience it is this set of

comprehensive set of programs that strikes a responsive

22

chord in the African-American community.

Having said that.

23

I wish to offer a word of support for needle exchange as

24

one strategy among many, all of which must be brought to

25

bear on the problem of stopping the spread of HIV among
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intravenous drug users.

Behavior change is very difficult

2

to bring about, but small changes in risk behavior mean

3

a lot when it comes to HIV transmission,and time is of

4

essence.

5

needles may not seem as great an accomplishment as getting

6

him or her off to kick the habit altogether.

7

with this one small step towards responsibility for

8

oneself and others, this one step is a giant leap for an

9

addict and a giant leap towards stopping the spread of HIV

10

Getting an intravenous drug user to stop sharing

However,

to their sexual partners and their unborn children.
Information from needle exchange programs in

11
12

this country, including one in Tacoma, again, checking my

13

resources for the report written earlier this year,

14

indicate the following:

15

before, has not increased as a result of needle exchange

16

programs.

17

users of the program, the median number of years the

18

participants have been using drugs intravenously is 14

19

years.

20

drug use pre-and post-participation in this program.

(1) Drug use, as has been stated

In Tacoma, of an estimated 300 to 350 regular

Further, there is no difference in the level of

(2) Needle exchange sites have proven to be

21

22

ideal sites for recruiting or referring individuals into

23

treatment.

24

recruited into treatment, half of which remained in

25

treatment.

Again, in Tacoma over 200 individuals were

This is one important feature that needs to be
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Needle exchange programs can be points of

1

underscored.

2

entry and access to a whole set of programs designed to

3

support the IV drug user in his or her journey away from

4

drug dependency.

5

outreach program, as Doctor Evans has stated.

In this sense it is another kind of

(3) From the standpoint of behavior change with

6

7

respect to the sharing of needles, the Tacoma program

8

reports that half of the individuals had already

9

eliminated needle sharing before entering the needle

10

exchange program, as a result of other prevention efforts.

11

The needle exchange program was able to get another third

12

to eliminate needle sharing as a behavior,and the use of

13

bleach increased 50 percent.
Clearly, needle exchange programs can fill gaps

14

15

left by other approaches to reach intravenous drug-using

16

populations and achieve behavior change.

17

another demonstration that we need an eclectic approach to

18

HIV

19

20

It is yet

evention utilizing many strategies, not one.
Needle exchange is not a panacea.

It is part of

a set of strategies that must be employed, including
treatment on demand, bleach and condom distribution and

22
23
24

25

information about the proper cleaning of drug
paraphernalia.
All needle exchange programs should be funded
and supported in a way that provides for good evaluation
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of the effectiveness of the program.

Because most

2

programs underway are new, it will take years and large

3

samples of individuals to determine how effective they

4

were in actually stopping the spread of HIV.

5

question for which there is no definite current answer.

6

What is known is that certain needle sharing behaviors

7

lead to HIV transmission and that needle exchange programs

8

are documenting reductions in this behavior as a direct

9

result of individual participation in needle exchange

10

This is a

programs.

11

To wait indefinitely for absolute proof, and

12

some members of the community demand that, that needle

13

exchange programs, the spread of HIV before instituting a

14

sanction program in California, a leading state in numbers

15

of diagnosed AIDS cases, is unreasonable in light of the

16

evidence that needle exchange programs do lead to

17

reduction in the behaviors that provide for the

18

transmission of HIV.

19

fund evaluation over a long run to ultimately answer the

20

question of efficacy.

21

What is reasonable is to require and

In conclusion, I would urge members of the

22

Committee on Health and Human Services to further examine

23

the objective data that is available on needle exchange.

24

The HIV crisis is closing in on its first decade.

25

Executive Director of an agency established to the respond

As the
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1

2

3
4

to the

c~isis

of AIDS in south Central Los Angeles, I am

well aware how unpopular needle exchange is in the
community here or elsewhere.

However, much that the

Minority AIDS Project and others have had to do to save

5

lives and take care of one of those in need, could not

6

wait for popular public outcry.

SENATOR WATSON:

7

Okay, then how do we address

8

the concerns that were just mentioned before, such as,

9

those of Commissioner Gray,and the religious community?
MR

10

GERALD:

I think that-- I've read the

11

objections by Commissioner Gray and I would support the

12

statements that have been made earlier about perhaps

13

legislation that made it legal for an agency to take on
is responsibility in the state of California.

14

Beyond

15

that we have to have quite a bit of community education

16

around this issue and basically, presenting the facts.

17

also think t

18

context of a comprehensive program that the community is

19

re

20
21
22

t we need to position this issue in the

ly demanding.

They are demanding more than just an

intervention around HIV.

They really are concerned about

the under ying issue of IV drug use.

And yes, a speaker

did speak about separating those issues.
to ask

I

n the community.

I think that's

23

a

I think people do want to

24

see more than just

25

how this program does get people into treatment, how this

they would like to hear more about
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program does,is a point of access to people who are not
2
3

currently accessed through existing programs.
SENATOR WATSON:

I would like to share with

4

you the letter from Commissioner Gray,and you might want

5

to look at it in terms of how you would respond.

6

you do that for us?

7

MR. GERALD:

8

SENATOR WATSON:

9

it with you.

Would

Yes, I would.
I'll have Mr. Stewart share

Here it is.

10

MR. GERALD:

I do have a copy of it.

11

SENATOR WATSON:

12

MR. GERALD:

13

SENATOR WATSON:

Oh, you have a copy of it?

Yes, I have seen it.
I'd be interested in seeing

14

your recommendations and your response to what she has

15

sent us, if you would.

16

MR. GERALD:

17

SENATOR WATSON:

18
19

Certainly.

and we appreciate what you've done and prepared for us.
MR. GERALD:

Thank you, Senator Watson.

20
21

Okay, thank you so very much,

(Witness was excused.)
SENATOR WATSON:

I'd like now to just skip

22

and call up Sherry Conroy of the Department of Alcohol and

23

Drug Programs because there are some questions that I'd

24

like her to respond to.

25

In the meanwhile, if Doctor Horowitz would come
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down in front, we'll take you right afterwards and
1

continue on with the agenda.
2

STATEMENT BY SHERRY CONROY
3

MS. CONROY:

Since you're running so far behind

4

and you were kind enough to accommodate my flight
5

schedule, I'll forego reading my testimony as submitted.
6

SENATOR WATSON:

Thank you. Just submit it,

7

8
9

and we '11 all get a chance to read it.
MS. CONROY:

Okay.

SENATOR WATSON:

Can I have the sergeant come

10
11

down and get a copy of her statement, please?
MS. CONROY:

Just to briefly summarize, the

12

first part of my testimony was to talk about the various
13
14

activities the department's been engaged in either
directly or through our 58 counties to prevent the spread

15

16

of HIV and AIDS.

We're very proud of those activities,so

1 would hope that you'll take a few minutes sometime later
17
18

o get acquainted with our activities.
Those activities involve training, education and

19

20

prevention

HIV testing with pre-and post-counseling: and

treatment on demand.

We see those as the three primary

21
22

strategies for my agency to be involved in.

The bottom

line of the testimony is, however, although the
23
24
25

preliminary data from needle exchange projects both
nationally and internationally, is promising, they do not
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prove definitively that they do not encourage the use of
2
3

drugs,and for that reason,our department does not support
needle exchange programs.
SENATOR WATSON:

4

5

end of it?
MS. CONROY:

6

9
10

That's it.

SENATOR WATSON:

7

8

Cut and dried, that's the

I know that it's difficult

when the word comes down from the top to take a position,
but I'm not clear.

You might want to reiterate for me why

you are against, at this point, the needle exchange

11

program

12

that it'?

because it does encourage the use of drugs, is

MS. CONROY:

13

Many of the needle exchange

14

programs, first of all, are not stringently,

15

scientifically designed to show that they do not encourage

16

drug use.
SENATOR WATSON:

17

Tell me this, on that point

18

right there, what is the Department doing to advance and

19

discourage the use of drugs?

20

21

discourage the use of drugs, what have you done
successfully?
MS. CONROY:

22
23

24
25

Advance your programs and

Well, I think we have a number of

things -SENATOR WATSON:
growth for AIDS.

And lowering the rate of
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MS. CONROY:

I think probably our best efforts

are our prevention information, both efforts in our
2

treatment programs and outreach efforts where we provide
3

information on how not to attract the HIV virus or spread
4

the virus.

I think our HIV testing plus counseling

5

program, in conjunction with the Office of AIDS within the
6

7
8

Department of Health Services,is extremely effective in
getting IV DU's to go into

SENATOR WATSON:

9
10

that it is extremely effective?
MS. CONROY:

11

12
13
14

extremely effective.

19

20

21
22
23

24
25

I believe that it will be extremely

effective.

SENATOR WATSON:
t

Okay, you pass this word on

I want to see the evidence that what you're doing is
paying off in terms of curtailing the spread of

17

18

We're in the early phases of it,

senator Watson, so I am remiss in saying that it is

15

16

What evidence do you have

AIDS in terms of reducing the number of those who use
IV's.

I'm not so sure I agree with you and I'm giving you

this word to pass on up and I really think that the
D rector might be more in agreement with this report than
u're able to say right now.

But

I really think we have

an epidemic on our hands,and I just haven't seen the
evidence coming out of the Department that what is being
done, and it's early I understand, is really recognizing
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what level of emergency we are at at the current time.
So just pass that word on that we're going to be

2

3

asking for documented evidence that the efforts through

4

the Department are really paying off.
MS. CONROY:

5

I really hear you, Senator Watson.

6

I'd like to say a couple of things.

One is a little bit

7

off track, but I think if you looked at the National

8

Household Survey on drug use we are seeing a drop in more

9

recreational drug use.

10

users, people that are addicts

SENATOR WATSON:

11

12

We still have hard core drug

For California, for the city

of Los Angeles, San Francisco, Richmond, Oakland?

13

MS. CONROY:

For California as a whole.

14

SENATOR WATSON:

I would be very impressed if

15

I could see that data on Los Angeles, San Diego, Richmond,

16

you know, the areas where the drug use is high.

17

see the national surveys they look at Podunk, Iowa, you

18

know, sure you had five people on drugs,and now you have

19

two.

20

here in California,and let's try to focus in on

21

California, particularly the urban centers and see what

22

we're doing in that regard.

23

When we

That doesn't really compare well with what we have

MS. CONROY:

Okay.

The other thing that I

24

wanted to say is the prior testimony that I skipped over

25

was the millions of dollars that we've committed for
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t~eatment

2
3
4

5

6

7
8
9
10
11

12
13

and

p~evention

fo~

HIV testing, pre and post-

counseling --

SENATOH WATSON:

And I do log the work we've

done to get that out to the Departments.

fight and there were people who challenged us all the way,
but the majority prevailed,and you now have the funds to
at least get started.

Now, I want you to track it very

carefully because we will like to see the data and to see
if the money we're investing is really paying off or have
we invested enough.
These are messages to be taken back.

16

Thank you

so very much and we appreciate you waiting this long.
MS. CONROY:

Thank you.
(Witness was excused.)

14

15

It was a big

SENATOH WATSON:

Doctor Horowitz, it is good

to see you.

17

DOCTOR HOROWITZ:

It's good to be seen.

18

SENATOR WATSON:

Pull that mike right up.

19

20
21

22

23
24
25

STATEMENT BY DOCTOR THOMAS HOROWITZ, M.D.
DOCTOR HOROWITZ:

It's good because of the time

that 90 percent of what I wanted to say was said and I see
no reason to go over it.
The two things we need to stress is that there
are numerous myths out there.

There is the myth that

anything to help a drug user encourages their use,and this
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has never been proven.

There is the myth that drug users

2

are incorrigible,and tests only at our Commission has

3

shown that we can have good inroads into the heroin-using

4

community.

5

of the nature of the drugs; and lastly, that anything we

6

do will interfere with law enforcement.

7

getting into delicate areas here.

8

to be done in such a way that is rational, both from a

9

public health viewpoint and a law enforcement viewpoint,

It's more difficult to hit cocaine use because

Obviously, we're

Obviously, any plan has

1o

but we've negotiated with law enforcement in many other

11

areas,and there's no reason why we can't be on the same

12

side, much as our outreach workers are seen as anti-drug

13

people on the streets.
It is a very, very strong anti-drug message when

14
15

you have community people, who are accepted in the

16

community, saying we're not going to give you any

17

morality; we're not going to give you any law; all we're

18

going to tell you is that this stuff is bad; it can kill

19

you.

20

more important, protect anyone you love.

21

message we have to get out onto the streets.

22

And, if you're going to use, protect yourself and
That's the

We're getting it there with our outreach workers,

23

but we have 30 of them and that's, you know, not a

24

significant number.

25

we have to look at needle exchange as a tool.

We need to increase that; therefore,
Clean
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1

needles are a tool in this war, but it still is not going

2

to build a house.

3

There has to be treatment on demand.

4

health educators who are accepted in the community.

5

find the outreach workers are the most useful.

6

have to be social service agencies that can work with the

7

outreach workers because these are street people,

8

frequently, people who aren't going to present to the

9

facilities, who don't have easy access to telephones to

It has to be put in the framework.
There has to be
We

There then

10

make the appointments and don't have easy transportation

11

to the facilities.
Additionally, there are the tools of education,

12
13

teaching them how to clean syringes if they continue to

14

use.

15

into treatment, and of course, it's pathetic but in L.A.;

16

the best we can do is a three-week wait,and for a person

17

with drug

18

work with that impulse.

19

they'll use.

20

21
22

23

When they're ready to go into treatment, how to get

se disease,they are impulsive,and you've got to
When they have the impulse to use,

When they have the impulse to go into

treatment, they'll go into treatment.
L.A. is a divided community and as such, as we
look at this issue,we find there are different solutions
in different communities,and you have to look at each

24

community separately.

It takes a different type of

25

outreach worker with a different message with different
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equipment, and the sad commentary is our hands are tied.
2

In Los Angeles we have not come to a conclusion

3

that a needle exchange program would be a major tool.

4

definitely wouldn't hurt,but I'm not sure it would be a

5

major advantage,and I'm still learning about it,and I'm

6

still studying it in each of the communities.

7

is that in communities which are convinced, such as San

8

Francisco, to have their hands tied is pathetic.

9

really what I feel today is all about.

10

have a

It

What is sad

That is

If we're going to

state policy, it has to be a state policy that

gives a path of least resistance to treatment programs and
12

to all the tools they need, and if we're going to have

13

just a local issue, the state policy has to allow it to be

14

a local issue without the hands being tied.

15

With the support of the Pharmacy Board, with the

16

support of the medical community, I believe that a

17

credible plan can be developed which will have limitations

18

so that it would not become a tool for the drug user but

19

stay what it needs to be, a tool for drug treatment.

20

person who uses drugs is going to afford those drugs

21

through criminal activity frequently or through

22

prostitution or through other acts that spread the virus,

23

and that is what it's important.

24

streets of the AIDS virus,it's safer for all of us,

25

including law enforcement, including our paramedics,

If we can clean the

A

86
including our emergency room personnel.
We have to look at this issue rationally rather
2

3
4

5
6
7
8

9

10
11

12
13
14

15

16
17
18

than emotionally.
charged.

unfortunately, it's emotionally

I cannot tell you what the Commission's stance

will be as time goes on.

more "bang per buck" from our outreach workers,but as I
said,there are communi ties where this may be a tool that
can help them.

I don't know that,but it's sad if we make

this decision,our hands would still be tied.

SENATOR WATSON:

Doctor Horowitz, I wonder if

you'll stay seated,and I'd like to hear from the next two
presenters, and maybe we can have an exchange as to how
we'd work with them.
The next two are Doctor Bruce Mitchell,
Commanding Officer of the Narcotics Division, Los Angeles
Police Department, and Commander Larry L. Anderson,
irman of the Los Angeles County Sheriff's Task Force.
Is Commander Anderson here?
MR. ANDERSON:

20

As it is now, we feel we get

SENATOR WATSON:

Yes.
Would you come and join us

please,and we'll take you as a panel here.
21
22

23
24

25

All right, Captain Mitchell.
STATEMENT BY CAPTAIN BRUCE MITCHELL
MR. MITCHELL:

Thank you very much for inviting

me to speak in front of the senate Health and Human
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Services Committee.
Since I was invited here to speak I'm going to

2

3

speak as a law enforcement professional, and address the IV

4

drug abuse problem from that perspective.

That includes

5

what I believe the effect on the crime rate is, the laws,

6

the victims and property loss.
The bottom line is the Los Angeles Police

7

8

Department does not support any form of a needle exchange

9

program,and I'll explain a little bit why we have that

10

position.
As you know, it's currently against the law.

11

12

There are a number of Health and Safety Code Sections that

13

prohibit the possession of hypodermic needles and many

14

other "paraphernalia", but to support any kind of a

15

program like this is, in effect, giving tacit approval to

16

drug addicts and users and indirectly supporting the

17

sellers of those illicit drugs.

18

officersrwe cannot condone breaking the law by supporting

19

drug abuse in order to solve a health problem.

As law enforcement

The City's crime rate under this program, as it

20

21

is right now, would just continue to remain unacceptably

22

high.

23

the property loss due to all types of theft crimes would

24

continue.

25

crime rates of the crimes of robbery, burglary, theft,

Citizens would still be vulnerable as victims and

IV drug usage has a direct correlation to the
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1

2

3
4

5
6
7

B
9
10
11

12
13
14

15
16

17

18
19

20

21

22

23
24
25

receiving stolen property, prostitution and shop lifting.
Because of the addictive nature of the heroin addict,
who is your typical IV drug user, they commit many more
crimes then the typical non-drug user.

The typical heroin

user has a habit of approximately $100 to $150 a day to
support his habit, and to support that habit, he has to
steal anywhere from $300 to $400 worth of property that
belongs to the citizens of the country, the city, or our
community to support that habit.

They're stealing from

the good citizens of this city to support their illegal
drug habit.
I think the link between drug use and crime has
been firmly established throughout the years,and one
cannot be at the exclusion of the other.

Localities

expressing high rates of illegal drug use also experience
high rates of criminal activity.
Some of the estimates that I've read on the
number of IV drug users in the City of Los Angeles, vary
from 60,000 to 100,000.

I heard some testimony today

about studies,and they indicate that there's no evidence
that a needle exchange program would cause the crime rates
to go up or IV drug users to increase in the number.
can they be so certain when the estimates are so wide,
from 60,000 up to 100,000.

SENATOR WATSON:

Let me ask you this.

If

How
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they already have a needle, and that's what I understand
2

the exchange program is, they already have a needle and

3

they're just replacing that needle, one for one.

4

MR. MITCHELL:

And the way we see that, that's

5

not going to stop your IV drug user from exchanging that

6

needle with their other users.

7

it-they'll purchase their heroin, that's usually right

8

downtown here in Los Angeles, and they'll take five and

9

six and seven people together

The way they typically use

they'll go over in some

10

corner where they are secreted from the public,and they

11

will heat up that heroin;and they will inject it right

12

there,and all six of those people will exchange that same

13

needle.

14

over from the previous shooting, or they have that needle

15

that they're using for the first time, they're still going

16

to share that needle.

17

So whether they have that one needle that is left

I think it's unrealistic to expect each and

18

every IV drug user to have a single needle that they use

19

one time and only for themselves.

SENATOR WATSON:

20

No, what I understand is

21

that you don't get a new one unless you have one to turn

22

in.

23

needle, you know, they only get one needle.

So, if twenty people use it it's still the same

24

MR. MITCHELL:

25

SENATOR WATSON:

That's correct.
You're not increasing the
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number of needles in circulation.
2

number of needles that are clean.

3

MR. MITCHELL:

You're increasing the

Or what are believed to be clean

4

and they would only be clean at the time the first person

5

uses the needle.

6

SENATOR WATSON:

7

MR. MITCHELL:

8

SENATOR WATSON:

13

Right, that's what 1

understand from the program.
MR. MITCHELL:

11

12

Apparently there would not be

more needles on the streets, from the program.

9
10

Correct.

I don't contradict or argue that

point.
With a needle exchange program,what is of

14

concern to me as a law enforcement professional with 25

15

years in law enforcement is that our heroin use today is

16

increasing.

17

increasing for the last few years.

18

It's gradually increasing and has been

SENATOR WATSON:

Now, let me ask you. Do you

19

think that's the result of a needle exchange program in

20

San Francisco?

21

MR. MITCHELL:

No.

But it's a part of the

22

problem in that heroin use is increasing,and at the same

23

tirne,our IV cocaine use is increasing.

24

little in that the typical heroin user will shoot up and

25

then they'll nod off for sometimes as short as an hour,

They differ a

91
sometimes as long as six and eight hours, something like
2

that.

It depends on that person's tolerance.

3

they'll shoot up again, and they'll shoot up again.

4

what's of concern to me is the cocaine user now who's also

5

using an IV, and by doing that, they have to shoot up much

6

more frequently.

7

frequent as every 30 minutes to sustain that high.

8

needle exchange program is not going to help this type of

9

a law enforcement problem.

But

Sometimes they'll have to shoot up as

SENATOR WATSON:

10

Then

A

But when you look at it

11

it's not only a law enforcement problem, it's a public

12

health problem too.

13

understand that awesome problem law enforcement has to do.

14

I understand also the epidemic nature of the problem in

15

terms of AIDS and the spread of AIDS.

That's what we're trying to solve.

16

The reason why the Health committee and not the

17

Judiciary Committee is holding this hearing is because we

18

are looking at it from a health standpoint.

19

MR. MITCHELL:

20

In fact, that was the next point I was going to

21

I understand that.

make.

22

SENATOR WATSON:

23

MR. MITCHELL:

Go ahead.
The department agrees that the

24

AIDS epidemic is a major health problem affecting the

25

entire U.S.,and we feel that we have to have a strategy

I
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1

that has a permanent solution;and the way to do that is

2

through public education and some of the treatment

3

programs that a number of your experts have already

4

mentioned.

5

those programs.

6

We're simply opposed to the needle exchange portion of any

7

of these outreach programs.

8
9
10

The Los Angeles Police Department supports
We're not opposed to any of the programs.

We have one program that we use in law
enforcement.

In the Los Angeles Police Department,we call

it the DARE program.

11

SENATOR WATSON:

12

MR. MITCHELL:

I'm very much aware of that.
My colleague also has a program

13

that is very much effective,and it is called the SANE

14

program.

15

school children.

16

say "no".

17

They both are designed to reach elementary
What we tell those children is how to

That's the message. we truly tell them how to

"no",and studies that have been conducted have shown

18

that programs like that do work.

Children who have been

19

exposed to the DARE program are less apt to use narcotics

20

than those who have not been exposed to it.

21

How do we tell a student at that age to say "no"

22

and absolutely never use narcotics, but by the way, if you

23

decide to use it,use a clean needle.

24

professional we're losing all credibility with our

25

children.

I think as a

We have to tell them don't use it.

We can't
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1

say don't use it, except if you do and add the needle

2

program.

3

convince our children that narcotics use is bad,we have to

4

tell them it's bad,and there are no exceptions.

5

have to have some treatment programs.

6

It doesn't work that way.

If we want to

Then we

How law enforcement can help there is by when a

7

person is identified as an IV drug user, we can see that

8

they're directed from the criminal justice system,and they

9

get that appropriate, permanent education, some long-term

10

programs.

And that's how we can help is in the

11

identifying abusers.
SENATOR WATSON:

12

I want to commend law

13

enforcement for its DARE program.

14

for that program, and it does pay off with young people.

15

we are concerned about those adults now that can father or

16

bear children, and what is happening to them, and how we

17

address this challenge.

18

with the use of crack cocaine, I'm listening and tuning in

19

to what we did during the suffrage period and what we did

20

with alcohol.

21

think in partnership,we can at least debate it, and

22

that's what this is all about.

23

I have a lot of respect

It's bigger than all of us.

Even

I don't know how to win this war and I

So, I want to thank you and Doctor Horowitz.

24

When we finish with the next witness I would like you to

25

comment.
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1
2

Let me ask now for Commander Anderson to
continue.

3

STATEMENT BY COMMANDER LARRY ANDERSON

4

MR. ANDERSON: Thank you, Senator.

5

Larry Anderson from the Los Angeles County Sheriff's

6

Department and for my statement I want to take about five

7

minutes, Senator, if you'll bear me out.

8
9

I'm Commander

The Los Angeles County Sheriff's Department
opposes any amendment to existing law that would permit

10

health authorities to have the discretion of providing a

11

needle exchange or distribution to intravenous drug

12

abusers.

13

California does prohibit the distribution or possession of

14

drug paraphernalia.

15

Of course, as you know, the current law in

The underlying issue that we're dealing with

16

today is really identifying and implementing programs that

17

might be effective in reducing the spread of HIV among

18

drug abusers.

19

that is being experimented with in several communities in

20

the United States.

21

exchange program was initiated in New York City in 1988,

22

and that report on results to date is not due until the

23

end of this year.

24

of IV drug abusers in the program represent only a

25

minuscule percentage of the number of IV drug users in New

Needle exchange is only one alternative

The first government-sponsored needle

It's apparent, however, that the number
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1

York and we're not aware of any data that would indicate

2

that needle exchange programs have been successful in

3

reducing seropositive rates among addicts.

4

further experimentation without valid information from

5

existing programs, we don't feel would be prudent.

6

To engage in

Needle exchange programs and needle exchange

7

does not prevent the sharing of needles, as Captain

8

Mitchell has mentioned previously.

9

spreads the virus.

It's the sharing that

Sharing a new needle is just as

10

dangerous a practice as sharing an old one.

11

sharing behavior that must be modified.

12

syringe is a method to allow a drug abuser to continue to

13

use unlawful substances.

14

It's the

Providing a new

Let's consider the message the government would

15

be sending out, especially to our young people after our

16

pronouncement of a national strategy to wage an all-out

17

war on drugs.

18

already receive too many mixed messages.

19

to compromise on this issue,and the message against drug

20

abuse must be clear.

21

problem is user-generated.

22

Our people and our young people in society
We can't afford

It must be recognized that our drug

Lawful alternatives to expanding the

23

availability of drug treatment programs must be thoroughly

24

considered.

25

has reported that 92,000 to 95,000 persons are being

The California Department of Health Services
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ted into drug treatment programs yearly, with about
2

35,000 of those persons in publicly funded Los Angeles

3

Coun

4

statewi

5

r

6

users recognized IV drug use as very related to getting

7

AIDS.

Programs.

Additionally, in a survey conducted

the state health officials, in a

esentative sample 96 percent of the intravenous drug

Nine

seven percent perceived sharing dirty

8

les as being very related to getting AIDS.

9

practice of their high-risk behavior didn't seem to
t awareness.

10

goi

to solve the problem.
The drug problem is one of demand.

13
14

5

Again, supplying a clean needle

the drug abuser is sharing it with another is not

11

12

However,

the

oblem in creating a market for

s c

The user is

illicit drugs

and every action must be considered in preventing drug
tifying those persons who need the
Ex i sti

f

d ug

law prohibiting the distribution and

drug paraphernalia provides us a means to
sers so that judicial action can be
ps rna

atory drug treatment should be

or those identified abusers who

have not

oluntary treatment and assistance.

WATSON:
t
25

t

l

e

1

If I might just

interru~t

S

the kind of thing that I propose but they

t

it's too costly.

I wanted mandatory
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1

treatment,but the state government or county government

2

would have to then fund that treatment and supply that

3

treatment.

4

also.

5

accessible.

6

But I think that's one of the solutions to it

And you heard the other witnesses say it's just not

MR. ANDERSON: That's the problem.

Effective

7

drug treatment programs need to be readily available to

8

anyone requesting help and at little or no expense to that

9

individual.

10

A significant legal question must also be

11

addressed concerning any legal exchange program.

12

this question.

13

with the knowledge that it would be used to inject an

14

unlawful and dangerous substance into the human body, that

15

government entity may be liable for the resulting

16

consequences including the death of an individual that

17

could reasonably be expected from such activity.

18

Consider

If a government entity furnishes a device

The solution to the drug abuse and health

19

problems is not in furnishing needles so that abusers can

20

continue their lifestyles.

21

are truly dedicated to winning the war against drugs

22

stemming the spread of disease, we will strengthen

23

prevention programs along with drug treatment availability

24

and without compromising our existing laws.

25

SENATOR WATSON:

If we as concerned citizens

I think you've raised some

and
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1

2
3
4

5

points

What we're

going to do is pull together the laws in the other states
where they do do legal exchange to see what the legal
implications are when there are bad results.

I think you

hit on some legal questions that we have to look at.
MR. ANDERSON: May I address that just for a

6

7

t we'll have to really consider.

moment, Senator?

8

SENATOR WATSON:

Sure.

9

MR. ANDERSON: Portland, Oregon has had a needle

10

exchange program,and in the state of Oregon,there is no

11

law against the possession of controlled, of needles, or

12

it was very easy for them to implement a program.

13

had no law that prevented that position.
In Tacoma, washington, I understand their

14

15

program
SENATOR WATSON:

16

7

They

from li

How does that exclude

them

ili

MR. ANDERSON: I don't know that it does.

18

I

don't know that it excludes anyone from liability.
20
21

WATSON:
and see

t

Well we'll check with Oregon

their experience has been.

MR. ANDERSON: In Tacoma, for example, I know as
23

was mentioned earlier by other speakers, I understand that

24

that pr

25

about $44,000;

ram was city-funded by the city of Tacoma for
and the State's Attorney General has
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recently ruled that the decision by the State Health
2

Officer was improper,

3

ordered that that program be shut down as far as expense

4

to the City of Tacoma.

5

State of washington right now.

6

and it was unlawful; and he has

That issue is in the courts in the

Boulder, Colorado was also mentioned a little

7

earlier.

8

needles is against the state law in Colorado,and the

9

District Attorney in Boulder, Colorado, I understand, has

10

given his permission for the health officials to engage in

11

the program and indicated he would not prosecute those

12

individuals for distributing needles to the IV drug

13

abusers.

14

That activity as far as the distribution of

New York is another matter.

There is all manner

15

of law,and all of the programs that were mentioned in

16

foreign countries, again, there's all manner of law, all

17

manner of culture, of social practice, grown up through

18

decades, and I think that it would be very imprudent for

19

us to base our programs against the practices of some of

20

those countries where their laws and social practices are

21

quite different from ours.

22

SENATOR WATSON:

I don't think that's our

23

intent at all.

24

states are doing and their experience.

25

Our intent is to find out what the other

I want to thank you two, and if you'll stay
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1

2
3
4

5

there, I'd like Doctor Horowitz, since you mentioned law
enforcement in your presentation, a way of working with
law enforcement to work out some of the problems,

thought you might like to comment on what you've heard.

8
g

10

11
12

13

DOCTOR HOROWITZ:

16

19

20
21
22

23
24
25

I am a proponent of

public health authorities having the ability to do what
they deem is necessary.

In looking at our Committee, we

have not seen this as a step that is appropriate for L.A.
county.

The reason being, I go out on the streets; I've

seen the shooting galleries off skid row, and I'm not
convinced that the needle would be used by one person as
ir prized possession.

Some would, but some wouldn't;

and the "bang for buck" I'm not sure is there.
a

I'm still

oponent that if we teach them what treatment's

avai able,
18

Of course, as I said, I'm not

a proponent of needle exchange.

14
15

I

think they've stated their positions rather well.

6
7

I

at social services are available, other ways

can be more careful, but understanding there is no
safe sex

there's safer sex.

there's safer drug use.

There is no safe drug use,

And, understanding it's a cost

benefit and they 1 re playing Russian roulette, and the only
difference is do they want to do it with a revolver until
they're re
it with an

to get into treatment or do they want to do
uzi?
The fact is, if you use drugs long enough and
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1

are involved in the activities it takes to afford the

2

drugs, people are going to get AIDS.

3

educate them and hope they learn before it's too late.

4

And as I said, my feeling is the outreach worker is the

5

most important tool.

6

issues and law enforcement, yes, something like the DARE

7

program.

8

more.

9

pacific, "You've got to be taught before it IS too late,

All we can do is

Therefore, we're looking at two

There's not enough money to do it right.

That's where we can influence kids.

We need

From the South

10

before your six, or seven or eight. "

11

them young, but then they go home and find parents who are

12

using.

13

streets around Hollywood who are into survival sex, into

14

drug use.

15

got to find ways to get to them.

16

innovative ways of keeping them from getting AIDS.

17

have to find better ways to educate the prostitutes and

18

the jobs.

19

20
21

We have to get to

We have 3,000 to 5,000 adolescents living on the

The DARE program won't work for them.

SENATOR WATSON:

We've

We've got to find
We

Any suggestions or

recommendations that any of the panel here might have?
DOCTOR HOROWITZ:

As I said, I think the

22

important thing is to have a dialogue and to start looking

23

for answers that don't cripple either of us.

24

25

SENATOR WATSON:

That's what we have done

here today is to bring people from all sides of the issue
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1

to take a look at it and discuss in a public forum.
I do thank all three of you and if you'd like to

2
3

make a closing remark -MR. MITCHELL:

4

Senator, if I may, just another

I mentioned during my presentation that

5

remark.

6

information that we had from the state of California

7

indicated that now, at this time, 92,000 to 95,000 people,

8

IV drug abusers, are being attracted into drug treatment

9

programs in the state of California.

Something is

10

attracting them into treatment.

11

to be looked at is that's a small number compared to what

12

we probably have in the state of California.

13

estimated that we probably have 120,000 in the Los Angeles

14

area

one, but the point is, I think,that we have to look

15

caref

ly at what kind of successes we're already having.
of programs do we already have?

16

It been

How can we

those programs that currently exist and give

17
18

However, I think what has

those

a hand who are trying to get the job done

t

r

WATSON:

I think people will go and

seek help 1f they know about it and if they have hit that
i

where they reach out.

What we need is the support,

the comm tment,and the advocacy.
very, very

1

Law enforcement could be

ul in asking that we have more money go in

and more expertise go into these programs so we can
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generalize them to the entire state.

There might be a

2

good program in the Bay Area, a good program down in San

3

Diego, but we have the problem statewide, and we do need to

4

have the correct appropriations to see that these programs

5

are more successful.

6

So, you may close.

7

MR. MITCHELL:

Excuse me, Senator Watson.

With

8

the President's new anti-drug program that is just

9

published today, as I understand, hopefully there will be

10

a lot more money for not only combat drug abuse, but for

11

treatment programs also.

12

some grant money available,and perhaps we could have some

13

type of a program that could combine law enforcement and

14

then track those people all the way through the treatment,

15

and maybe that could be a pilot program.

16
17

SENATOR WATSON:

Sure.

MR. MITCHELL:

19

SENATOR WATSON:

You bet I will.
Thank you.

23
24
25

I appreciate all

of you.
(Witnesses were excused.)

21

22

Could you say that

loud and long, please?

18

20

I'm sure there is going to be

SENATOR WATSON:

Finally, John Drown, the

Director of a local· Aids agency.

Mr. Brown?

Mr. Brown will be our last speaker unless there
is someone with just a burning desire to say something.
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STATEMENT BY JOHN BROWN

1

MR. BROWN:
3

i

me to the agenda.
As the Executive Director of an agency that is

4

5
6
7

8
9

,0
11

12
13
14

15
16

Thank you, Senator Watson, for

in street outreach here in Los Angeles County and

invo

as part of a coalition of both county and state-contracted
outreach programs here in Los Angeles County, one
additional perspective I have as someone who has been
involved in AIDS education and AIDS prevention since
virtually
Coun

inning of the epidemic here in Los Angeles

, we really have adopted,and I have adopted,a

agmatic attitude toward these things.

Of course, we

support a needle distribution exchange type of program.

I

think what we see as a problem, or what our frustration is
here

n Los Angeles especially, in dealing with a very

conservative Board of Supervisors that has authority over
cy, is that little things become very important,
inc

ng te

think

inology and the way things are being worded.

ery good example of this is in the
zat ons that come up when you talk about pro-

on as o

sed to pro-choice.

Now here today you

testimony at all that has talked
about needle distribution and its values

23
24

alone as an intervention.

w th a c

It's all been in conjunction

ehensive program in which needle distribution
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is certainly a part of.

But condom distribution and

2

bleach distribution is also an important part.

3

no studies at all that have looked comparatively at the

4

value of needle distribution as opposed to the value of

5

condom and bleach distribution.

6

terms of the impact that outreach, comprehensive outreach

7

has had on affecting HIV infection in a given area.

a
g

There is

It has all talked in

Here in Los Angeles, we have, through necessity,
have had to use a lot of very creative ways to do

10

intervention.

We're proud of the things that we've done

11

even though we haven't-- talking about needle

12

distribution is abstract-- we can't even distribute

13

condoms and bleach in Los Angeles County.

14

we have experienced in the last round with the Board of

15

Supervisors, that in fact, the inclusion of needle

16

distribution and actually the focus of needle distribution

17

on that outreach package, that comprehensive outreach

18

package, in many ways led to a major kind of policy

19

decision that prevented us from even using condoms and

20

bleach.

21

that we see very little possibility of anything happening

22

the near future to really get needle distribution going as

It may be,and

What our concern is, being out there daily is

23 . part of the comprehensive outreach that's happening in
24

this state.

But, at the same time, we're frustrated over

25

the fact that we can't even get bleach and condoms out on
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street because it has been linked to this "package'',
in the way, you know, early on abortion was linked to
anning.

When the focus becomes, when you're

about needle exchange, and what you're really
5
6
7

8
9

t
A

ki

about is comprehensive outreach, comprehensive
outreach, because you're not talking about needle

exchange alone, what you're doing is you're using
terminology that incites a certain reaction.

And, if, in

fact, we can keep the perspective that certainly with all
best conditions, needle exchange would be a wonder

10

ng to have as part of outreach, that really as Doctor

11

tz said, the most effective thing out there is the

12

Hor

13

outreach worker.
e,

14

The person who is out there saying to

we care", and anything we can give them,

it's a needle exchange program or condoms and
i

's got to be looked at as what it really is.
DS outreach package, it's an AIDS outreach

focus being on needle exchange programs as
to AIDS outreach programs might sound like a petty
int, but really it is our experience that we lost,
e talking about a year into this, that we lost
e of condoms and bleach and the distribution of
condoms

ble

over the needle exchange issue.

I would just like to say in closing, that we
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appreciate you conducting these hearings and keeping this
2

issue alive,and the leadership you have taken in regards

3

to AIDS and substance abuse; and in the future if there

4

could be more of an emphasis on the establishment of a

5

definition of comprehensive AIDS outreach and the

6

implementation of comprehensive AIDS outreach without

7

necessarily always focusing on the fact that, or calling

8

this a needle exchange program, even though needle

9

exchange does need to be part of it.

10

SENATOR WATSON:

I

think we certainly get

1·1

your point,and I think you're absolutely right.

12

start breaking this program up in component parts and

13

throwing up those red flags, we're in serious trouble with

14

a moral outrage reaction.

15

describe what it is we want to do.

16

program certainly is what we would like to use as a goal.

17

When we

We do need to learn how best to
And a comprehensive

As we conclude the hearing today,

I just want to

18

say that I think we are a little more enlightened.

We

19

certainly will take this information back to Sacramento.

20

We'd like to call on you to assist us in thinking through

21

what the program ought to be.

22

legislation will come out of today's hearing.

23

earlier this morning Senator Seymour's legislation was the

24

focus of our hearing.

25

needle exchange,and we did talk about that because that is

I am not sure what kind of
I do know

This afternoon we talked about
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1

a highly controversial program that is being casually or

2

illegally operated on the streets, but one of great

3

interest because it pretends to be,might be one of the

4

facets of an overall program.
There will be continued debate.

5

6

s

7

testimony,and I will now adjourn this meeting.

8
g
10
11

12
13

14

5

nding the afternoon with us.

I thank you for

I thank you for your

(Whereupon, at 4:09p.m., the above-entitled
matter was concluded.)
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